U.S. patent application number 13/233365 was filed with the patent office on 2012-01-19 for acridone derivatives as labels for fluorescence detection of target materials.
This patent application is currently assigned to GE HEALTHCARE UK LIMITED. Invention is credited to JOHN ANTHONY SMITH, RICHARD MARTIN WEST.
Application Number | 20120015373 13/233365 |
Document ID | / |
Family ID | 9915775 |
Filed Date | 2012-01-19 |
United States Patent
Application |
20120015373 |
Kind Code |
A1 |
SMITH; JOHN ANTHONY ; et
al. |
January 19, 2012 |
ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET
MATERIALS
Abstract
Disclosed are methods for assay of an analyte employing acridone
dyes having the structure: ##STR00001## Z.sup.1 and Z.sup.2
represent atoms necessary to complete one ring, two fused ring,
three fused ring aromatic or heteroaromatic systems, each ring
having five or six atoms selected from carbon atoms and optionally
no more than two atoms selected from oxygen, nitrogen and sulphur;
R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are selected from hydrogen,
halogen, amide, hydroxyl, cyano, nitro, mono- or
di-nitro-substituted benzyl, amino, mono- or di-C.sub.1-C.sub.4
alkyl-substituted amino, sulphydryl, carbonyl, carboxyl,
C.sub.1-C.sub.6 alkoxy, acrylate, vinyl, styryl, aryl, heteroaryl,
C.sub.1-C.sub.20 alkyl, aralkyl, sulphonate, sulphonic acid,
quaternary ammonium, the groups -E-F and --(CH.sub.2--).sub.nY;
R.sup.1 is selected from hydrogen, mono- or di-nitro-substituted
benzyl, C.sub.1-C.sub.20 alkyl, aralkyl, the groups -E-F and
--(CH.sub.2--).sub.nY; where E is a spacer group, F is a target
bonding group; Y is selected from sulphonate, sulphate,
phosphonate, phosphate, quaternary ammonium and carboxyl.
Inventors: |
SMITH; JOHN ANTHONY;
(Cardiff, GB) ; WEST; RICHARD MARTIN; (Cardiff,
GB) |
Assignee: |
GE HEALTHCARE UK LIMITED
LITTLE CHALFONT
GB
|
Family ID: |
9915775 |
Appl. No.: |
13/233365 |
Filed: |
September 15, 2011 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
11943628 |
Nov 21, 2007 |
8034558 |
|
|
13233365 |
|
|
|
|
10479578 |
Dec 1, 2003 |
|
|
|
PCT/GB02/02509 |
May 30, 2002 |
|
|
|
11943628 |
|
|
|
|
Current U.S.
Class: |
435/7.1 ;
436/501 |
Current CPC
Class: |
C09B 15/00 20130101;
G01N 33/582 20130101 |
Class at
Publication: |
435/7.1 ;
436/501 |
International
Class: |
G01N 33/566 20060101
G01N033/566 |
Foreign Application Data
Date |
Code |
Application Number |
Jun 4, 2001 |
GB |
0113435.2 |
Claims
1-36. (canceled)
37. A method for the assay of an analyte in a sample, the method
comprising: i) contacting the analyte with a specific binding
partner for said analyte under conditions suitable to cause the
binding of at least a portion of said analyte to said specific
binding partner to form a complex and wherein one of said analyte
and said specific binding partner is labelled with a fluorescent
dye of formula: ##STR00027## wherein: groups R.sup.2 and R.sup.3
are attached to the Z.sup.1 ring structure and groups R.sup.4 and
R.sup.5 are attached to the Z.sup.2 ring structure; Z.sup.1 and
Z.sup.2 independently represent the atoms necessary to complete one
ring, two fused ring, or three fused ring aromatic or
heteroaromatic systems, each ring having five or six atoms selected
from carbon atoms and optionally no more than two atoms selected
from oxygen, nitrogen and sulphur; at least one of groups R.sup.1,
R.sup.2, R.sup.3, R.sup.4 and R.sup.5 is the group -E-F where E is
a spacer group having a chain from 1-60 atoms selected from the
group consisting of carbon, nitrogen, oxygen, sulphur and
phosphorus atoms and F is a target bonding group; when any of said
groups R.sup.2, R.sup.3, R.sup.4 and R.sup.5 is not said group
-E-F, said remaining groups R.sup.2, R.sup.3, R.sup.4 and R.sup.5
are independently selected from hydrogen, halogen, amide, hydroxyl,
cyano, amino, mono- or di-C.sub.1-C.sub.4 alkyl-substituted amino,
sulphydryl, carbonyl, carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate,
vinyl, styryl, aryl, heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl,
sulphonate, sulphonic acid, quaternary ammonium and the group
--(CH.sub.2--).sub.nY; and, when group R.sup.1 is not said group
-E-F, it is selected from hydrogen, C.sub.1-C.sub.20 alkyl, aralkyl
and the group --(CH.sub.2--).sub.nY; Y is selected from sulphonate,
sulphate, phosphonate, phosphate, quaternary ammonium and carboxyl;
and n is an integer from 1 to 6; ii) measuring the fluorescence
lifetime of the labelled complex; and iii) correlating the
fluorescence lifetime with the presence or the amount of said
analyte in said sample.
38. The method of claim 37, wherein said fluorescent dye has a
fluorescence lifetime in the range from 2 to 30 nanoseconds.
39. The method of claim 37, wherein Z.sup.1 and Z.sup.2
independently represent the atoms necessary to complete a phenyl or
a naphthyl ring structure.
40. The method of claim 37, wherein said target bonding group F
comprises either: i) a reactive group selected from carboxyl,
succinimidyl ester, sulpho-succinimidyl ester, isothiocyanate,
maleimide, haloacetamide, acid halide, hydrazide, vinylsulphone,
dichlorotriazine and phosphoramidite; or ii) a functional group
selected from hydroxy, amino, sulphydryl, imidazole, carbonyl
including aldehyde and ketone, phosphate and thiophosphate.
41. The method of claim 37, wherein said spacer group E is selected
from: --(CHR').sub.p-- --{(CHR').sub.q--O--(CHR').sub.r}.sub.s--
--{(CHR').sub.q--NR'--(CHR').sub.r}.sub.s--
--{(CHR').sub.q--(CH.dbd.CH)--(CHR').sub.r}.sub.s--
--{(CHR').sub.q--Ar--(CHR').sub.r}.sub.s--
--{(CHR').sub.q--CO--NR'--(CHR').sub.r}.sub.s--
--{(CHR').sub.q--CO--Ar--NR'--(CHR').sub.r}.sub.s-- where R' is
hydrogen, C.sub.1-C.sub.4 alkyl or aryl, which may be optionally
substituted with sulphonate, Ar is phenylene, optionally
substituted with sulphonate, p is 1-20, preferably 1-10, q is 0-10,
r is 1-10 and s is 1-5.
42. The method of claim 37, wherein at least one of groups R.sup.1,
R.sup.2, R.sup.3, R.sup.4 and R.sup.5 comprises the group
--(CH.sub.2--).sub.nY, where Y is selected from sulphonate,
sulphate, phosphonate, phosphate, quaternary ammonium and carboxyl
and n is zero or an integer from 1 to 6.
43. The method of claim 37, wherein said analyte-specific binding
partner pairs are selected from the group consisting of
antibodies/antigens, lectins/glycoproteins, biotin/streptavidin,
hormone/receptor, enzyme/substrate or co-factor, DNA/DNA, DNA/RNA
and DNA/binding protein.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a divisional of U.S. patent application
Ser. No. 11/943,628 filed Nov. 21, 2007, which is a continuation of
U.S. patent application Ser. No. 10/479,578 filed Dec. 1, 2003,
abandoned, which is a filing under 35 U.S.C. .sctn.371 and claims
priority to international patent application number
PCT/GB2002/002509 filed May 30, 2002, published on Dec. 12, 2002,
as WO 2002/099424, which claims priority to patent application
number GB 0113435.2 filed Jun. 4, 2001.
BACKGROUND OF THE INVENTION
[0002] 1. Field of the Invention
[0003] The present invention relates to new acridone derivatives
having characteristic fluorescence lifetimes that can be used as
labels for attachment to and labelling of target materials. The
acridone derivatives of the invention may be easily distinguished,
one from the other, by virtue of their fluorescence lifetimes and
they may be used in multiparameter applications. The invention also
relates to assay methods utilising acridone derivatives and to a
set of different fluorescent acridone lifetime dyes.
[0004] 2. Description of the Prior Art
[0005] There is an increasing interest in, and demand for,
fluorescent labels for use in the labelling and detection of
biological materials. Fluorescent labels are generally stable,
sensitive and a wide range of methods are now available for the
labelling of biomolecules. Typically, the emission spectrum of a
fluorescent dye is a characteristic property of the dye, the
intensity of such emission being used in the detection of materials
labelled with that dye. One problem with measurements of
fluorescence intensity as a means of detecting and/or measuring the
concentration of a fluorescent labelled biomolecule is that
background fluorescence may interfere with the measurement. Thus,
in order to obtain improvements in the sensitivity of fluorescence
detection, it is highly desirable to improve the signal-to-noise
ratio.
[0006] One means of overcoming the problem of background noise has
been through the use of long wavelength dyes, for example, the
cyanine dyes Cy.TM.5 and Cy7, as disclosed in U.S. Pat. No.
5,268,486 (Waggoner et al). These dyes emit in the 600-800 nm
region of the spectrum, where background fluorescence is much less
of a problem. Another means of improving the signal-to-noise ratio
in fluorescence measurements is in the use of time-resolved
fluorescence, for example by using fluorescent labels based on
lanthanide chelates, eg. Eu.sup.3+ and Tb.sup.3+ (Selvin et al,
U.S. Pat. No. 5,622,821). In time-resolved fluorescent labels, the
lifetime of the fluorescence emission is typically longer than that
of the background fluorescence, which may therefore be gated out
using appropriate instrumentation.
[0007] McGown, L. B. et al (Anal. Chem., (2000), 72, 5865-73)
describe the use of a range of different dyes for multiparameter
analysis in which fluorescence lifetime, rather than fluorescence
wavelength, is the discriminating characteristic. Dyes from
different dye classes were used to obtain lifetime resolution;
however compensation was required for either mobility differences
or different fluorescence signal intensities. The method has been
refined by Sauer, M. et al (J. Fluorescence, (1993), 3 (3),
131-139) who employed a series of rhodamine-based fluors having a
range of fluorescent lifetimes but which all absorb and emit at
similar wavelengths, thus avoiding having to change the excitation
source and emission filters.
[0008] The acridone chromophore is highly fluorescent and has been
used for labelling biological molecules and subsequent detection by
conventional fluorescence emission spectroscopy. For example,
Faller, T. et al (J. Chem. Soc. Chem. Comm., (1997), 1529-30)
describe the preparation of a succinimidyl ester derivative of
acridone and its use in labelling peptides for subsequent analysis
by mass-spectroscopy. U.S. Pat. No. 5,472,582 (Jackson) describes
the use of the fluorescent label, 2-aminoacridone, for labelling
and detecting carbohydrates in a mixture, following electrophoretic
separation.
[0009] Val'kova, G. et al (Dokl. Akad. Nauk. SSR, (1978), 240 (4),
884-7) have measured the fluorescence lifetimes of several acridone
derivatives, however, to date, there appear to be no reports
relating to the use of acridones as lifetime dyes suitable for
labelling and the detection of biological materials.
SUMMARY OF THE INVENTION
[0010] The present invention therefore describes modifications of
the acridone chromophore, to produce a range of acridone
derivatives having characteristic fluorescence lifetimes and which
are useful for labelling biological materials.
[0011] The acridone derivatives of the present invention moreover
provide a valuable set of fluorescent labels having a common core
structure and which are particularly useful for multiparameter
analysis. In each dye of a set of dyes, the absorption and emission
spectra remain essentially the same, whilst the fluorescence
lifetimes vary. Thus, it is possible to use a common excitation
source and determine the lifetimes at the same emission wavelength,
thereby simplifying requirements for detection instrumentation used
in multiparameter experiments. Another advantage of the present
invention is that the fluorescence lifetimes of the acridone dye
derivatives are generally longer than the lifetimes of other
fluorescent labels, as well as naturally occurring fluorescent
materials, such as proteins and polynucleotides, thereby allowing
easy discrimination from background fluorescence in biological
assays utilising such dyes.
[0012] Accordingly, in a first aspect of the present invention
there is provided use of a reagent for labelling and lifetime
detection of a target material, wherein said reagent is a dye of
the formula (I):
##STR00002##
wherein: groups R.sup.2 and R.sup.3 are attached to the Z.sup.1
ring structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure; Z.sup.1 and Z.sup.2 independently represent
the atoms necessary to complete one ring, two fused ring, or three
fused ring aromatic or heteroaromatic systems, each ring having
five or six atoms selected from carbon atoms and optionally no more
than two atoms selected from oxygen, nitrogen and sulphur; R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 are independently selected from
hydrogen, halogen, amide, hydroxyl, cyano, nitro, mono- or
di-nitro-substituted benzyl, amino, mono- or di-C.sub.1-C.sub.4
alkyl-substituted amino, sulphydryl, carbonyl, carboxyl,
C.sub.1-C.sub.6 alkoxy, acrylate, vinyl, styryl, aryl, heteroaryl,
C.sub.1-C.sub.20 alkyl, aralkyl, sulphonate, sulphonic acid,
quaternary ammonium, the group -E-F and the group
--(CH.sub.2--).sub.nY; R.sup.1 is selected from hydrogen, mono- or
di-nitro-substituted benzyl, C.sub.1-C.sub.20 alkyl, aralkyl, the
group -E-F and the group --(CH.sub.2--).sub.nY; E is a spacer group
having a chain from 1-60 atoms selected from the group consisting
of carbon, nitrogen, oxygen, sulphur and phosphorus atoms and F is
a target bonding group; Y is selected from sulphonate, sulphate,
phosphonate, phosphate, quaternary ammonium and carboxyl; and n is
an integer from 1 to 6.
[0013] In a first embodiment of the first aspect, the dye of
formula (I) is a fluorescent dye wherein:
groups R.sup.2 and R.sup.3 are attached to the Z.sup.1 ring
structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure, where Z.sup.1 and Z.sup.2 are hereinbefore
defined; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently
selected from hydrogen, halogen, amide, hydroxyl, cyano, amino,
mono- or di-C.sub.1-C.sub.4 alkyl-substituted amino, sulphydryl,
carbonyl, carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate, vinyl,
styryl, aryl, heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl,
sulphonate, sulphonic acid, quaternary ammonium, the group -E-F and
the group --(CH.sub.2--).sub.nY; and R.sup.1 is selected from
hydrogen, C.sub.1-C.sub.20 alkyl, aralkyl, the group -E-F and the
group --(CH.sub.2--).sub.nY; wherein E, F, Y and n are hereinbefore
defined.
[0014] The acridone dyes according to the first embodiment of the
first aspect are particularly suitable for use as fluorescence
lifetime dyes. In the context of the present invention, the term
lifetime dye is intended to mean a dye having a measurable
fluorescence lifetime, defined as the average amount of time that
the dye remains in its excited state following excitation
(Lackowicz, J. R., Principles of Fluorescence Spectroscopy, Kluwer
Academic/Plenum Publishers, New York, (1999)).
[0015] Preferably, the fluorescent dye has a fluorescence lifetime
in the range from 2 to 30 nanoseconds, more preferably from 2 to 20
nanoseconds.
[0016] In a second embodiment of the first aspect, the dye of
formula (I) is a non-fluorescent or substantially non-fluorescent
dye wherein:
groups R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Z.sup.1 and
Z.sup.2 are hereinbefore defined; and wherein at least one of
groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 comprises at
least one nitro group.
[0017] In this embodiment, suitably, the at least one nitro group
may be attached directly to the Z.sup.1 and/or Z.sup.2 ring
structures. In the alternative, a mono- or di-nitro-substituted
benzyl group may be attached to the R.sup.1, R.sup.2, R.sup.3,
R.sup.4 or R.sup.5 positions, which optionally may be further
substituted with one or more nitro groups attached directly to the
Z.sup.1 and/or Z.sup.2 ring structures.
[0018] Preferably, in the first and second embodiments, at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 in the
dye of formula (I) is the group -E-F where E and F are hereinbefore
defined.
[0019] Suitably, the target bonding group F is a reactive or
functional group. A reactive group of a compound according to
formula (I) can react under suitable conditions with a functional
group of a target material; a functional group of a compound
according to formula (I) can react under suitable conditions with a
reactive group of the target material such that the target material
becomes labelled with the compound.
[0020] Preferably, when F is a reactive group, it is selected from
succinimidyl ester, sulpho-succinimidyl ester, isothiocyanate,
maleimide, haloacetamide, acid halide, vinylsulphone,
dichlorotriazine, carbodiimide, hydrazide and phosphoramidite.
Preferably, when F is a functional group, it is selected from
hydroxy, amino, sulphydryl, imidazole, carbonyl including aldehyde
and ketone, phosphate and thiophosphate. By virtue of these
reactive and functional groups the compounds of formula (I) may be
reacted with and covalently bond to target materials.
[0021] Suitably, Z.sup.1 and Z.sup.2 may be selected independently
from the group consisting of phenyl, pyridinyl, naphthyl,
anthranyl, indenyl, fluorenyl, quinolinyl, indolyl,
benzothiophenyl, benzofuranyl and benzimidazolyl moieties.
Additional one, two fused, or three fused ring systems will be
readily apparent to the skilled person. Preferably, Z.sup.1 and
Z.sup.2 are selected from the group consisting of phenyl,
pyridinyl, naphthyl, quinolinyl and indolyl moieties. Particularly
preferred Z.sup.1 and Z.sup.2 are phenyl and naphthyl moieties.
[0022] Preferably, at least one of the groups R.sup.1, R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 of the dyes of formula (I) is a water
solubilising group for conferring a hydrophilic characteristic to
the compound. Solubilising groups, for example, sulphonate,
sulphonic acid and quaternary ammonium, may be attached directly to
the aromatic ring structures Z.sup.1 and/or Z.sup.2 of the compound
of formula (I). Alternatively, solubilising groups may be attached
by means of a C.sub.1 to C.sub.6 alkyl linker chain to said
aromatic ring structures and may be selected from the group
--(CH.sub.2--).sub.nY where Y is selected from sulphonate,
sulphate, phosphonate, phosphate, quaternary ammonium and carboxyl;
and n is an integer from 1 to 6. Alternative solubilising groups
may be carbohydrate residues, for example, monosaccharides.
Examples of water solubilising constituents include C.sub.1-C.sub.6
alkyl sulphonates, such as --(CH.sub.2).sub.3--SO.sub.3.sup.- and
--(CH.sub.2).sub.4--SO.sub.3.sup.-. However, one or more sulphonate
or sulphonic acid groups attached directly to the aromatic ring
structures of a dye of formula (I) are particularly preferred.
Water solubility may be advantageous when labelling proteins.
[0023] Suitable spacer groups E may contain 1-60 chain atoms
selected from the group consisting of carbon, nitrogen, oxygen,
sulphur and phosphorus.
For example the spacer group may be: [0024] --(CHR').sub.p-- [0025]
--{(CHR').sub.q--O--(CHR').sub.r}.sub.s-- [0026]
--{(CHR').sub.q--S--(CHR').sub.r}.sub.s-- [0027]
--{(CHR').sub.q--NR'--(CHR').sub.r}.sub.s-- [0028]
--{(CHR').sub.q--(CH.dbd.CH)--(CHR').sub.r}.sub.s-- [0029]
--{(CHR').sub.q--Ar--CHR').sub.r}.sub.s-- [0030]
--{(CHR').sub.q--CO--NR'--(CHR').sub.r}.sub.s-- [0031]
--{(CHR').sub.q--CO--Ar--NR'--(CHR').sub.r}.sub.s-- where R' is
hydrogen, C.sub.1-C.sub.4 alkyl or aryl, which may be optionally
substituted with sulphonate, Ar is phenylene, optionally
substituted with sulphonate, p is 1-20, preferably 1-10, q is 0-10,
r is 1-10 and s is 1-5.
[0032] Specific examples of reactive groups R.sup.1, R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 and the groups with which R.sup.1,
R.sup.2, R.sup.3, R.sup.4 and R.sup.5 can react are provided in
Table 1. In the alternative, groups R.sup.1, R.sup.2, R.sup.3,
R.sup.4 and R.sup.5 may be the functional groups of Table 1 that
would react with the reactive groups of a target material.
TABLE-US-00001 TABLE 1 Possible Reactive Substituents and Sites
Reactive Therewith Reactive Groups Functional Groups succinimidyl
esters primary amino, secondary amino isothiocyanates amino groups
haloacetamides, maleimides sulphydryl, imidazole, hydroxyl, amine
acid halides amino groups anhydrides primary amino, secondary
amino, hydroxyl hydrazides, aldehydes, ketones vinylsulphones amino
groups dichlorotriazines amino groups carbodiimides carboxyl groups
phosphoramidites hydroxyl groups
[0033] Preferred reactive groups which are especially useful for
labelling target materials with available amino and hydroxyl
functional groups include:
##STR00003##
where n is 0 or an integer from 1-10.
[0034] Aryl is an aromatic substituent containing one or two fused
aromatic rings containing 6 to 10 carbon atoms, for example phenyl
or naphthyl, the aryl being optionally and independently
substituted by one or more substituents, for example halogen,
hydroxyl, straight or branched chain alkyl groups containing 1 to
10 carbon atoms, aralkyl and C.sub.1-C.sub.6 alkoxy, for example
methoxy, ethoxy, propoxy and n-butoxy.
[0035] Heteroaryl is a mono- or bicyclic 5 to 10 membered aromatic
ring system containing at least one and no more than 3 heteroatoms
which may be selected from N, O, and S and is optionally and
independently substituted by one or more substituents, for example
halogen, hydroxyl, straight or branched chain alkyl groups
containing 1 to 10 carbon atoms, aralkyl and C.sub.1-C.sub.6
alkoxy, for example methoxy, ethoxy, propoxy and n-butoxy.
[0036] Aralkyl is a C.sub.1 to C.sub.6 alkyl group substituted by
an aryl or heteroaryl group.
[0037] Halogen and halo groups are selected from fluorine,
chlorine, bromine and iodine.
[0038] Exemplary dyes according to the first embodiment of the
first aspect are as follows: [0039] i)
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate [0040] ii)
O--(N-succinimidyl)-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate
[0041] iii)
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-4-carboxamido)hexanoate
[0042] iv)
O--(N-succinimidyl)-6-(2-acetamido-9-oxo-9H-acridin-10-yl)hexanoate.
[0043] The dyes of the present invention may be used to label and
thereby impart fluorescent properties to a variety of target
biological materials. Thus, in a second aspect, there is provided a
method for labelling a target biological material, the method
comprising:
i) adding to a liquid containing said target biological material a
dye of formula (I):
##STR00004##
wherein: groups R.sup.2 and R.sup.3 are attached to the Z.sup.1
ring structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure, where Z.sup.1 and Z.sup.2 are hereinbefore
defined; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently
selected from hydrogen, halogen, amide, hydroxyl, cyano, amino,
mono- or di-C.sub.1-C.sub.4 alkyl-substituted amino, sulphydryl,
carbonyl, carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate, vinyl,
styryl, aryl, heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl,
sulphonate, sulphonic acid, quaternary ammonium, the group -E-F and
the group --(CH.sub.2--).sub.nY; R.sup.1 is selected from hydrogen,
C.sub.1-C.sub.20 alkyl, aralkyl, the group -E-F and the group
--(CH.sub.2--).sub.nY; where E, F, Y and n are hereinbefore
defined; and ii) incubating said dye with said target biological
material under conditions suitable for labelling said target.
[0044] Suitably, the fluorescent dyes of the present invention
wherein at least to one of the groups R.sup.1 to R.sup.5 contains a
charge, for example, quaternary amino, may be used to bind
non-covalently to charged biological molecules such as, for
example, DNA and RNA. Alternatively, fluorescent dyes of the
present invention wherein at least one of the groups R.sup.1 to
R.sup.5 is an uncharged group, for example, a long chain alkyl or
an aryl group, may be used to bind to is uncharged biological
molecules such as, for example, biological lipids, as well as to
intact cell membranes, membrane fragments and cells.
[0045] In a preferred embodiment, at least one of the groups
R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 in the dye of
formula (I) is the group -E-F where E and F are hereinbefore
defined. In this embodiment, the fluorescent dyes may be used to
covalently label a target biological material. The target bonding
group may be a reactive group for reacting with a functional group
of the target material. Alternatively, the target bonding group may
be a functional group for reacting with a reactive group on the
target biological material. The method comprises incubating the
target material with an amount of the dye according to the
invention under conditions to form a covalent linkage between the
target and the dye. The target may be incubated with an amount of a
compound according to the present invention having at least one of
groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 that includes
a reactive or functional group as hereinbefore defined that can
covalently bind with the functional or reactive group of the target
biological material.
[0046] Suitable biological materials include, but are not limited
to the group consisting of antibody, lipid, protein, peptide,
carbohydrate, nucleotides which contain or are derivatized to
contain one or more of an amino, sulphydryl, carbonyl, hydroxyl and
carboxyl, phosphate and thiophosphate groups, and oxy or deoxy
polynucleic acids which contain or are derivatized to contain one
or more of an amino, sulphydryl, carbonyl, hydroxyl and carboxyl,
phosphate and thiophosphate groups, microbial materials, drugs,
hormones, cells, cell membranes and toxins.
[0047] The fluorescent dyes according to the invention having a
target bonding group in at least one of groups R.sup.1, R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 may be used in an assay method for
determining the presence or the amount of an analyte in a sample.
Thus, in a third aspect of the present invention, there is provided
a method for the assay of an analyte in a sample which method
comprises:
i) contacting the analyte with a specific binding partner for said
analyte under conditions suitable to cause the binding of at least
a portion of said analyte to said specific binding partner to form
a complex and wherein one of said analyte and said specific binding
partner is labelled with a fluorescent dye of formula (I):
##STR00005##
wherein: groups R.sup.2 and R.sup.3 are attached to the Z.sup.1
ring structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure, where Z.sup.1 and Z.sup.2 are hereinbefore
defined; at least one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4
and R.sup.5 is the group -E-F where E is a spacer group having a
chain from 1-60 atoms selected from the group consisting of carbon,
nitrogen, oxygen, sulphur and phosphorus atoms and F is a target
bonding group; when any of said groups R.sup.2, R.sup.3, R.sup.4
and R.sup.5 is not said group -E-F, said remaining groups R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 are independently selected from
hydrogen, halogen, amide, hydroxyl, cyano, amino, mono- or
di-C.sub.1-C.sub.4 alkyl-substituted amino, sulphydryl, carbonyl,
carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate, vinyl, styryl, aryl,
heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl, sulphonate, sulphonic
acid, quaternary ammonium and the group --(CH.sub.2--).sub.nY; and,
when group R.sup.1 is not said group -E-F, it is selected from
hydrogen, C.sub.1-C.sub.20 alkyl, aralkyl and the group
--(CH.sub.2--).sub.nY; wherein Y and n are hereinbefore defined;
ii) measuring the emitted fluorescence of the labelled complex; and
iii) correlating the emitted fluorescence with the presence or the
amount of said analyte in said sample.
[0048] Suitably, step ii) may be performed by measurement of the
fluorescence intensity or fluorescence lifetime of the sample,
preferably the fluorescence lifetime.
[0049] In one embodiment, the assay method is a direct assay for
the measurement of an analyte in a sample. Optionally, a known or
putative inhibitor compound may be included in the assay mix.
[0050] In a second, or alternative embodiment, the assay may be a
competitive assay wherein a sample containing an analyte competes
with a fluorescent tracer for a limited number of binding sites on
a binding partner that is capable of specifically binding the
analyte and the tracer. Suitably, the tracer is a labelled analyte
or a labelled analyte analogue, in which the label is a fluorescent
dye of formula (I). Increasing amounts (or concentrations) of the
analyte in the sample will reduce the amount of the fluorescent
labelled analyte or fluorescent labelled analyte analogue that is
bound to the specific binding partner. The fluorescence signal is
measured and the concentration of analyte may be obtained by
interpolation from a standard curve.
[0051] In a further embodiment, the binding assay may employ a
two-step format, wherein a first component (which may be optionally
coupled to an insoluble support) is bound to a second component to
form a specific binding complex, which is bound in turn to a third
component. In this format, the third component is capable of
specifically binding to either the second component, or to the
specific binding complex. Either of the second or the third
component may be labelled with a fluorescent dye according to the
present invention. Examples include "sandwich" assays, in which one
component of a to specific binding pair, such as a first antibody,
is coated onto a surface, such as the wells of a multiwell plate.
Following the binding of an antigen to the first antibody, a
fluorescent labelled second antibody is added to the assay mix, so
as to bind with the antigen-first antibody complex. The
fluorescence signal is measured and the concentration of antigen
may be obtained by is interpolation from a standard curve.
[0052] Examples of analyte-specific binding partner pairs include,
but are not restricted to, antibodies/antigens,
lectins/glycoproteins, biotin/streptavidin, hormone/receptor,
enzyme/substrate or co-factor, DNA/DNA, DNA/RNA and DNA/binding
protein. It is to be understood that any molecules which possess a
specific binding affinity for each other may be employed, so that
the fluorescent dyes of the present invention may be used for
labelling one component of a specific binding pair, which in turn
may be used in the detection of binding to the other component.
[0053] The fluorescent dyes according to first embodiment of the
first aspect may be used in applications that include detecting and
distinguishing between various components in a mixture. Thus, in a
fourth aspect, the present invention provides a set of two or more
different fluorescent dyes according to the invention, each dye of
said set of dyes having the formula (I):
##STR00006##
wherein: groups R.sup.2 and R.sup.3 are attached to the Z.sup.1
ring structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure, where Z.sup.1 and Z.sup.2 are hereinbefore
defined; R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently
selected from hydrogen, halogen, amide, hydroxyl, cyano, amino,
mono- or di-C.sub.1-C.sub.4 alkyl-substituted amino, sulphydryl,
carbonyl, carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate, vinyl,
styryl, aryl, heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl,
sulphonate, sulphonic acid, quaternary ammonium, the group -E-F and
the group --(CH.sub.2--).sub.nY; R.sup.1 is selected from hydrogen,
C.sub.1-C.sub.20 alkyl, aralkyl, the group -E-F and the group
--(CH.sub.2--).sub.nY; E is a spacer group having a chain from 1-60
atoms selected from the group consisting of carbon, nitrogen,
oxygen, sulphur and phosphorus atoms and F is a target bonding
group; Y is selected from sulphonate, sulphate, phosphonate,
phosphate, quaternary ammonium and carboxyl; and n is an integer
from 1 to 6; wherein each dye of said set has a distinguishably
different fluorescence lifetime compared with the lifetimes of the
remaining dyes of the set.
[0054] Preferably, in each dye of the set of dyes at least one of
groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 is the group
-E-F where E and F are hereinbefore defined.
[0055] Preferably, the set of fluorescent dyes according to the
invention will comprise four different dyes, each dye of the set
having a different fluorescence lifetime.
[0056] Preferably, each of the fluorescent dyes in the set has a
fluorescence lifetime in the range from 2 to 30 nanoseconds. More
preferably the fluorescent dyes in the set will have fluorescence
lifetimes in the range from 2 to 20 nanoseconds.
[0057] To distinguish between different dyes in the set of dyes,
the difference in the lifetimes of the fluorescent emission of two
such dyes is preferably at least 15% of the value of the shorter
lifetime dye.
[0058] The set of dyes may be used in a detection method wherein
different fluorescent dyes of the set of dyes are covalently bonded
to a plurality of different primary components, each primary
component being specific for a different secondary component, in
order to identify each of a plurality of secondary components in a
mixture of secondary components. The method comprises covalently
binding different dyes of a set of fluorescent dyes according to
the fourth aspect of the invention to different primary components
in a multicomponent mixture wherein each dye of the set has a
different fluorescence lifetime, compared with the fluorescence
lifetimes of the remaining dyes of the set; adding the dye-labelled
primary components to a preparation containing secondary components
under conditions to enable binding of at least a portion of each of
said dye-labelled primary components to its respective secondary
component; and determining the presence or the amount of the bound
secondary component by measuring the fluorescence lifetime of each
of the labelled primary component-secondary component
complexes.
[0059] If required, any unreacted primary components may be removed
or separated from the preparation by, for example washing, to
prevent interference with the analysis.
[0060] Preferably, a single wavelength of excitation can be used to
excite fluorescence from two or more materials in a mixture, where
each fluoresces having a different characteristic fluorescent
lifetime.
[0061] The set of fluorescent dyes according to the present
invention may be used in any system in which the creation of a
fluorescent primary component is possible. For example, an
appropriately reactive fluorescent dye according to the invention
can be conjugated to a DNA or RNA fragment and the resultant
conjugate then caused to bind to a complementary target strand of
DNA or RNA. Other examples of primary component-secondary component
complexes which may be detected include antibodies/antigens and
biotin/streptavidin.
[0062] The set of dyes according to the present invention may also
be advantageously used in fluorescent DNA sequencing based upon
fluorescence lifetime discrimination of the DNA fragments. Briefly,
each one of a set of dyes, may be coupled to a primer. Various
primers are available, such as primers from pUC/M13, .lamda.gt10,
.lamda.gt11 and the like (see Sambrook et al, Molecular Cloning, A
Laboratory Manual 2.sup.nd Edition, Cold Spring Harbour Laboratory
Press 1989). DNA sequences are cloned into an appropriate vector
having a primer sequence joined to the DNA fragment to be
sequenced. After hybridisation to the DNA template, polymerase
enzyme-directed synthesis of a complementary strand occurs.
Different 2',3'-dideoxynucleotide terminators are employed in each
different sequencing reaction so as to obtain base-specific
termination of the chain extension reaction. The resulting set of
DNA fragments are separated by electrophoresis and the terminating
nucleotide (and thus the DNA sequence) is determined by detecting
the fluorescence lifetime of the labelled fragments. DNA sequencing
may also be performed using dideoxynucleotide terminators
covalently labelled with the fluorescent dyes according to the
present invention.
[0063] The non-fluorescent or substantially non-fluorescent dyes
according to the second embodiment of the first aspect may be used
as the substrate for an enzyme and which upon reaction with the
enzyme, yields a fluorescent product.
[0064] Bacterial nitroreductases have been shown to catalyse the
general reaction set out below in Reaction Scheme 1.
##STR00007##
where, in the presence of NADH or NADPH, one or more nitro groups
on an organic molecule may be reduced to a hydroxylamine (--NHOH)
group which to may subsequently be converted to an amine
(--NH.sub.2) group.
[0065] Thus, in a fifth aspect of the invention, there is provided
a method of increasing the fluorescence of a dye of formula
(I):
##STR00008##
wherein: groups R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5,
Z.sup.1 and Z.sup.2 are hereinbefore defined and wherein at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
comprises at least one nitro group; characterised by the reduction
of said at least one nitro group to --NHOH or --NH.sub.2
[0066] Preferably, the fluorescence lifetime of the fluorescent
product of the reduction is in the range from 2 to 30
nanoseconds.
[0067] Suitably, reduction is by means of nitroreductase. This can
be achieved by enzymatic conversion of a nitro group in a compound
of formula (I) to a --NHOH or --NH.sub.2 group by the action of the
nitroreductase. Depending on the structure of the dye, the
fluorescence emission from the product of the nitroreductase
reaction may typically have a lifetime in the range 2 to 30
nanoseconds. Moreover, the fluorescence lifetime characteristics of
the reaction product can be altered to suit the application by
means of additional substitutents, whilst retaining the nitro
group(s) that are involved in the reaction with nitroreductase.
Thus, fluorescent reporters compatible for use with other fluors in
multiplex systems can be provided.
[0068] In a sixth aspect of the invention there is provided a
method for detecting nitroreductase enzyme activity in a
composition comprising:
i) mixing under conditions to promote nitroreductase activity said
composition with a dye of formula (I):
##STR00009##
wherein: groups R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5,
Z.sup.1 and Z.sup.2 are hereinbefore defined and wherein at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
comprises at least one nitro group; and ii) measuring an increase
in fluorescence wherein said increase is a measure of the amount of
nitroreductase activity.
[0069] Suitably, the measurement of step ii) may be of the
fluorescence intensity and/or fluorescence lifetime of the dye.
[0070] In one embodiment of the sixth aspect, the composition
comprises a cell or cell extract. In principle, any type of cell
can be used, i.e. prokaryotic or eukaryotic (including bacterial,
mammalian and plant cells). Where appropriate, a cell extract can
be prepared from a cell, using standard methods known to those
skilled in the art (Molecular Cloning, A Laboratory Manual 2.sup.nd
Edition, Cold Spring Harbour Laboratory Press 1989), prior to
measuring fluorescence.
[0071] Typical conditions for nitroreductase activity comprise
incubation of the composition in a suitable medium and the dye at
approximately 37.degree. C. in the presence of NADH and FMN.
[0072] In a seventh aspect of the invention there is provided an
assay method comprising:
i) binding one component of a specific binding pair to a surface;
ii) adding a second component of the specific binding pair under
conditions to promote binding between the components, said second
component being labelled with a nitroreductase enzyme; iii) adding
a dye of formula (I):
##STR00010##
wherein: groups R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5,
Z.sup.1 and Z.sup.2 are hereinbefore defined and wherein at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
comprises at least one nitro group; and iv) detecting binding of
the second component to the first component by measuring an
increase in fluorescence as a measure of bound nitroreductase
activity.
[0073] In a preferred embodiment of the seventh aspect, said
specific binding pair is selected from the group consisting of
antibodies/antigens, lectins/glycoproteins, biotin/streptavidin,
hormone/receptor, enzyme/substrate, DNA/DNA, DNA/RNA and
DNA/binding protein.
[0074] Briefly, an in vitro assay method for the detection of
antibody binding may be configured as follows. An antibody specific
for an antigen of interest may be labelled by covalently linking it
to an enzymatically active nitroreductase. The labelled antibody
can then be introduced into the test sample containing the antigen
under conditions suitable for binding. After washing to remove any
unbound antibody, the amount of bound antibody is detected by
incubating the sample with a substrate comprising a compound of
formula (I) having at least one nitro group under conditions for
nitroreductase activity and measuring an increase in fluorescence.
The amount of fluorescence detected will be proportional to the
amount of nitroreductase-labelled antibody that has bound to the
antigen.
[0075] In an in vitro assay for detecting the binding of nucleic
acids by hybridisation, either of the pair of target and probe
nucleic acid is immobilised by attachment to a membrane or surface.
The second member of the pair is labelled with nitroreductase and
incubated under hybridising conditions with the immobilised nucleic
acid. Unbound, labelled nucleic acid is washed off and the amount
of bound, labelled nucleic acid is measured by incubating the
membrane or surface with a compound of formula (I) having at least
one nitro group under conditions suitable for nitroreductase
activity. The amount of increase in fluorescence gives a measure of
the amount of bound labelled DNA.
[0076] Methods for coupling enzymes, such as nitroreductase, to
other biomolecules, e.g. proteins and nucleic acids, are well known
(Bioconjugate Techniques, Academic Press 1996). Coupling may be
achieved by direct means, for example by use of a suitable
bifunctional crosslinking agent (e.g. N-[.gamma.-maleimidopropionic
acid]hydrazine, Pierce) to covalently link the enzyme and binding
partner. Alternatively, coupling may be achieved by indirect means,
for example by separately biotinylating the enzyme and the binding
partner using a chemically reactive biotin derivative, (e.g.
N-hydroxysuccinimido-biotin, Pierce) and subsequently coupling the
molecules through a streptavidin bridging molecule.
[0077] Cell based assays are increasingly attractive over in vitro
biochemical assays for use in high throughput screening (HTS). This
is because cell based assays require minimal manipulation and the
readouts can be examined in a biological context that more
faithfully mimics the normal physiological situation. Such in vivo
assays require an ability to measure a to cellular process and a
means to measure its output. For example, a change in the pattern
of transcription of a number of genes can be induced by cellular
signals triggered, for example, by the interaction of an agonist
with its cell surface receptor or by internal cellular events such
as DNA damage. The induced changes in transcription can be
identified by fusing a reporter gene to is a promoter region which
is known to be responsive to the specific activation signal.
[0078] In fluorescence-based enzyme-substrate systems, an increase
in fluorescence gives a measure of the activation of the expression
of the reporter gene.
[0079] Accordingly, in a eighth aspect of the invention, there is
provided an assay method which comprises:
i) contacting a host cell which has been transfected with a nucleic
acid molecule comprising expression control sequences operably
linked to a sequence encoding a nitroreductase, with a dye of
formula (I):
##STR00011##
wherein: groups R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5,
Z.sup.1 and Z.sup.2 are hereinbefore defined and wherein at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
comprises at least one nitro group; and ii) measuring an increase
in fluorescence as a measure of nitroreductase gene expression.
[0080] In one embodiment of the eighth aspect, the assay method is
conducted in the presence of a test agent whose effect on gene
expression is to be determined.
[0081] Methods for using a variety of enzyme genes as reporter
genes in mammalian cells are well known (for review see Naylor L.
H., Biochemical Pharmacology, (1999), 58, 749-757). The reporter
gene is chosen to allow is the product of the gene to be measurable
in the presence of other cellular proteins and is introduced into
the cell under the control of a chosen regulatory sequence which is
responsive to changes in gene expression in the host cell. Typical
regulatory sequences include those responsive to hormones, second
messengers and other cellular control and signalling factors. For
example, agonist binding to seven transmembrane receptors is known
to modulate promoter elements including the cAMP responsive
element, NF-AT, SRE and AP1; MAP kinase activation leads to
modulation of SRE leading to Fos and Jun transcription; DNA damage
leads to activation of transcription of DNA repair enzymes and the
tumour suppressor gene p53. By selection of an appropriate
regulatory sequence the reporter gene can be used to assay the
effect of added agents on cellular processes involving the chosen
regulatory sequence under study.
[0082] For use as a reporter gene, the nitroreductase gene may be
isolated by well known methods, for example by amplification from a
cDNA library by use of the polymerase chain reaction (PCR)
(Molecular Cloning, A Laboratory Manual 2.sup.nd Edition, Cold
Spring Harbour Laboratory Press (1989) pp 14.5-14.20). Once
isolated, the nitroreductase gene may be inserted into a vector
suitable for use with mammalian promoters (Molecular Cloning, A
Laboratory Manual 2.sup.nd Edition, Cold Spring Harbour Laboratory
Press (1989) pp 16.56-16.57) in conjunction with and under the
control of the gene regulatory sequence under study. The vector
containing the nitroreductase reporter and associated regulatory
sequences may then be introduced into the host cell by transfection
using well known techniques, for example by use of DEAE-Dextran or
Calcium Phosphate (Molecular Cloning, A Laboratory Manual 2.sup.nd
Edition, Cold Spring Harbour Laboratory Press (1989) pp
16.30-16.46). Other suitable techniques will be well known to those
skilled in the art.
[0083] In another embodiment of the eighth aspect, the dye of
formula (I) wherein groups R.sup.1, R.sup.2, R.sup.3, R.sup.4,
R.sup.5, Z.sup.1 and Z.sup.2 are hereinbefore defined and wherein
at least one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and
R.sup.5 comprises at least one nitro group, is permeable to cells.
In this embodiment, preferably, at least one is of groups R.sup.1,
R.sup.2, R.sup.3, R.sup.4 or R.sup.5 comprises a cell membrane
permeabilising group. Membrane permeant compounds can be generated
by masking hydrophilic groups to provide more hydrophobic
compounds. The masking groups can be designed to be cleaved from
the substrate within the cell to generate the derived substrate
intracellularly. Because the substrate is more hydrophilic than the
membrane permeant derivative it is then trapped in the cell.
Suitable cell membrane permeabilising groups may be selected from
acetoxymethyl ester which is readily cleaved by endogenous
mammalian intracellular esterases (Jansen, A. B. A. and Russell, T.
J., J. Chem. Soc., (1965), 2127-2132 and Daehne W. et al. J. Med.
Chem., (1970) 13, 697-612) and pivaloyl ester (Madhu et al., J.
Ocul. Pharmacol. Ther., (1998), 14 (5), 389-399) although other
suitable groups will be recognised by those skilled in the art.
[0084] Typically, to assay the activity of a test agent to activate
cellular responses via the regulatory sequence under study, cells
transfected with the nitroreductase reporter are incubated with the
test agent, followed by addition of a dye of formula (I) wherein at
least one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
in said dye comprises at least one nitro group, said compound being
made cell permeant. After an appropriate period required for
conversion of the substrate to a form exhibiting fluorescence, the
fluorescence from the cells is measured at an emission wavelength
appropriate for the chosen dye. Measurement of fluorescence may be
readily achieved by use of a range of detection instruments
including fluorescence microscopes (e.g. LSM 410, Zeiss),
microplate readers (e.g. CytoFluor 4000, Perkin Elmer), CCD imaging
systems (e.g. LEADseeker.TM., Amersham Pharmacia Biotech) and Flow
Cytometers (e.g. FACScalibur, Becton Dickinson).
[0085] The measured fluorescence is compared with fluorescence from
control cells not exposed to the test agent and the effects, if
any, of the test agent on gene expression modulated through the
regulatory sequence, is determined by the detection of the
characteristic fluorescence in the test cells. Where appropriate, a
cell extract can be prepared using conventional is methods.
[0086] Suitable means for expressing a nitroreductase enzyme
include an expression plasmid or other expression construct.
Methods for preparing such expression constructs are well known to
those skilled in the art.
[0087] In an ninth aspect of the present invention, there is
provided a dye of formula (I):
##STR00012##
wherein: groups R.sup.2 and R.sup.3 are attached to the Z.sup.1
ring structure and groups R.sup.4 and R.sup.5 are attached to the
Z.sup.2 ring structure; Z.sup.1 and Z.sup.2 independently represent
the atoms necessary to complete one ring, two fused ring, or three
fused ring aromatic or heteroaromatic systems, each ring having
five or six atoms selected from carbon atoms and optionally no more
than two atoms selected from oxygen, nitrogen and sulphur; at least
one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 is the
group -E-F where E is a spacer group having a chain from 1-60 atoms
selected from the group consisting of carbon, nitrogen, oxygen,
sulphur and phosphorus atoms and F is a target bonding group; and,
when any of said groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and
R.sup.5 is not said group -E-F, said remaining groups R.sup.2,
R.sup.3, R.sup.4 and R.sup.5 are independently selected from
hydrogen, halogen, amide, hydroxyl, cyano, nitro, amino, mono- or
di-C.sub.1-C.sub.4 alkyl-substituted amino, sulphydryl, carbonyl,
carboxyl, C.sub.1-C.sub.6 alkoxy, acrylate, vinyl, styryl, aryl,
heteroaryl, C.sub.1-C.sub.20 alkyl, aralkyl, sulphonate, sulphonic
acid, quaternary ammonium and the group --(CH.sub.2--).sub.nY; and,
when group R.sup.1 is not said group -E-F, it is selected from
hydrogen, mono- or di-nitro-substituted benzyl, C.sub.1-C.sub.20
alkyl, aralkyl and the group --(CH.sub.2--).sub.nY; E is a spacer
group having a chain from 1-60 atoms selected from the group
consisting of carbon, nitrogen, oxygen, sulphur and phosphorus
atoms and F is a target bonding group; Y is selected from
sulphonate, sulphate, phosphonate, phosphate, quaternary ammonium
and carboxyl; and n is an integer from 1 to 6; provided that at
least one of groups R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5
is a water solubilising group.
[0088] Preferably, the target bonding group F comprises a reactive
group for reacting with a functional group on a target material, or
a functional group for reacting with a reactive group on a target
material. Preferred reactive groups may be selected from carboxyl,
succinimidyl ester, sulpho-succinimidyl ester, isothiocyanate,
maleimide, haloacetamide, acid halide, hydrazide, vinylsulphone,
dichlorotriazine and phosphoramidite. Preferred functional groups
may be selected from hydroxy, amino, sulphydryl, imidazole,
carbonyl including aldehyde and ketone, phosphate and
thiophosphate.
[0089] Preferably, the spacer group E is selected from: [0090]
--(CHR').sub.p-- [0091] --{(CHR').sub.q--O--(CHR').sub.r}.sub.s--
[0092] --{(CHR').sub.q--NR'--(CHR').sub.r}.sub.s-- [0093]
--{(CHR').sub.q--(CH.dbd.CH)--(CHR').sub.r}.sub.s-- [0094]
--{(CHR').sub.q--Ar--(CHR).sub.r}.sub.s-- [0095]
--{(CHR').sub.q--CO--NR'--(CHR').sub.r}.sub.s-- [0096]
--{(CHR').sub.q--CO--Ar--NR'--(CHR').sub.r}.sub.s-- where R' is
hydrogen, C.sub.1-C.sub.4 alkyl or aryl, which may be optionally
substituted with sulphonate, Ar is phenylene, optionally
substituted with sulphonate, p is 1-20, preferably 1-10, q is 0-10,
r is 1-10 and s is 1-5.
[0097] The dyes of formula (I) may be prepared from the
corresponding diphenylamine-2-carboxylic acid according to
published methods (see Albert, A. and Ritchie, B., Org. Syntheses,
(1942), 22, 5; also U.S. Pat. No. 3,021,334). Suitably, the
diphenylamine-2-carboxylic acid may be heated in the presence of an
acidic dehydrating agent such as phosphorus oxychloride or
concentrated sulfuric acid. The diphenylamine-2-carboxylic acid
derivatives may be prepared by reaction of a 2-halobenzoic acid
with a suitable primary aminobenzene (having at least one aryl ring
position unsubstituted ortho- to the amino group), which reaction
may be performed in the presence of catalytic copper metal/salt
(see Ullmann, F., Chem. Ber., (1903), 36, 2382; also British Patent
649147). Suitably, the 2-halobenzoic acid is heated with the
aminobenzene, in the presence of a base such as an alkali metal
carbonate, in a solvent such as 1-butanol or 1-pentanol. A
catalytic amount of copper metal powder or a copper salt such as
anhydrous copper acetate is also usually included, although
sometimes this is not required.
[0098] It will be readily appreciated that certain dyes of the
present invention may be useful as intermediates for conversion to
other dyes by methods well known to those skilled in the art. The
dyes of the present invention may be synthesized by the methods
disclosed herein. Derivatives of the compounds having a particular
utility are prepared either by selecting appropriate precursors or
by modifying the resultant compounds by known methods to include
functional groups at a variety of positions. As examples, the dyes
of the present invention may be modified to include certain
reactive groups for preparing a dye according to the present
invention, or charged or polar groups may be added to enhance the
solubility of the compound in polar or nonpolar solvents or
materials. As examples of conversions, an ester may be converted to
a carboxylic acid or may be converted to an amido derivative.
Groups R.sup.1 to R.sup.5 may be chosen so that the dyes of the
present invention have different lifetime characteristics, thereby
providing a number of related dyes which can be used in
multiparameter analyses wherein the presence and quantity of
different compounds in a single sample may be differentiated based
on the wavelengths and lifetimes of a number of detected
fluorescence emissions. The dyes of the present invention may be
made soluble in aqueous, other polar, or non-polar media containing
the material to be labelled by appropriate selection of
R-groups.
BRIEF DESCRIPTION OF THE DRAWINGS
[0099] FIG. 1 shows the absorbance spectra (1A) and the emission
spectra (1B) of four acridone dyes according to the present
invention;
[0100] FIG. 2 shows the fluorescence lifetime decay plot of four
acridone dyes according to the present invention, as follows:
[0101] --------------: N-(succinyl)-2-amino-10H-acridine-9-one;
[0102] : 6-(9-oxo-9H-acridin-10-yl)hexanoic acid;
[0103] --- --- --- ---: 6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoic
acid;
[0104] --- ---: 6-(9-oxo-9H-acridin-4-carboxamido) hexanoic
acid;
[0105] FIG. 3 shows lifetime decay plots of protein conjugates as
follows: Conjugate 1=6-(9-oxo-9H-acridin-10-yl)hexanoic
acid--bovine serum albumin (BSA) conjugate; Conjugate
2=6-(9-oxo-9H-acridin-4-carboxamido) hexanoic acid--rabbit serum
albumin conjugate;
[0106] FIG. 4 is a lifetime decay plot following
immunoprecipitation with anti-BSA antibody as described in Example
16;
[0107] FIG. 5 illustrates fluorescence lifetime detection in
capillary electrophoresis of four acridone dye-labelled DNA
fragments as described in Example 17;
[0108] FIG. 6 shows the lifetime detection of a mixture of two
different acridone dye-labelled BSA conjugates and
co-electrophoresed in SDS PAGE as described in Example 19.
[0109] Cy.TM. is a trademark of Amersham Biosciences UK
Limited.
EXAMPLES
[0110] The present examples are provided for illustrative purposes
only, and are not to be construed as limiting the present invention
as defined by the appended claims. All references given below and
elsewhere in the present specification are hereby included herein
by reference.
1. O--(N-Succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate
##STR00013##
[0111] 1.1 O-Ethyl-6-(9-oxo-9H-acridin-10-yl)hexanoate
[0112] 9-(10H)-Acridone (4.88 g, 25 mmol) was mixed with anhydrous
methyl sulfoxide (25 ml) under nitrogen atmosphere and set
stirring. After 5 minutes, the resultant yellow slurry was treated
with potassium tert-butoxide (3.37 g, 30 mmol) and stirring
continued until all the solids had dissolved. Ethyl
6-bromohexanoate (6.7 g, 30 mmol) was then added and the resulting
solution stirred under nitrogen for 3 days. At the end of this time
the reaction mixture was poured into water (1000 ml) and extracted
with ethyl acetate. The organic solution was washed with 0.5M
aqueous HCl, then with water, before being dried (MgSO.sub.4),
filtered and evaporated under vacuum.
[0113] The crude product was separated from unreacted acridone by
trituration with 1:1 ethyl acetate/hexane; acridone remained
undissolved and was filtered off. The filtrate was washed twice
with 0.5M aqueous HCl before being dried (MgSO.sub.4), filtered and
evaporated under vacuum; the acid wash removed most of the
O-alkylated acridine side product. The residue was then subjected
to flash column chromatography (silica. 30-50% ethyl
acetate/hexane) to give 5.9 g (70%) of
O-ethyl-6-(9-oxo-9H-acridin-10-yl)hexanoate. This material was
finally recrystallized from ethanol (20 ml) to give 5.14 g of
analytically pure material. .lamda..sub.max (EtOH)=404, 387, 254
nm; .delta..sub.H (300 MHz, CD.sub.3OD) 1.23 (3H, t), 1.60 (2H, m),
1.73 (2H, m), 1.92 (2H, m), 2.37 (2H, t), 4.11 (2H, q), 4.50 (2H,
app.t) 7.34 (2H, m), 7.77 (2H, m), 7.84 (2H, m) and 8.46 (2H, m).
Mass spectrum: (ES+) 338 (M+H), 360 (M+Na).
1.2 6-(9-Oxo-9H-acridin-10-yl)hexanoic acid
[0114] O-Ethyl-6-(9-oxo-9H-acridin-10-yl)hexanoate (3.40 g, 10
mmol) was mixed with acetic acid (40 ml) and 1.0M aqueous HCl (10
ml). The resulting solution was heated under reflux for 3 hrs until
TLC indicated complete conversion to the carboxylic acid
(RPC.sub.18. Methanol, 90: water, 10. R.sub.f=0.6). The solution
was evaporated under vacuum, then co-evaporated with acetonitrile
until a yellow solid was obtained. This was triturated with diethyl
ether and dried under high vacuum over phosphorus pentoxide to give
6-(9-oxo-9H-acridin-10-yl)hexanoic acid (3.07 g, 98%).
.lamda..sub.max (EtOH)=404, 384, 256 nm. .delta..sub.H (300 MHz,
CD.sub.3OD) 1.62 (2H, m), 1.75 (2H, m), 1.95 (2H, m), 2.36 (2H, t),
4.53 (2H, app.t), 7.35 (2H, m), 7.79 (2H, m), 7.86 (2H, m) and 8.46
(2H, m). Mass spectrum: (ES+) 310 (M+H), 332 (M+Na). Melting
Point=167.degree. C.
1.3 O--(N-Succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate
[0115] 6-(9-Oxo-9H-acridin-10-yl)hexanoic acid (309 mg, 1.0 mmol)
and O--(N-succinimidyl)-N,N,N',N'-tetramethyluronium
tetrafluoroborate (TSTU; 301 mg, 1.0 mmol) were dissolved in
N,N-dimethylformamide (5 ml). To the resulting solution was added
N,N-diisopropylethylamine (183 .mu.l, 1.05 mmol). After 2 hrs the
solvent was evaporated under vacuum. The residue was purified by
flash chromatography (silica. 0-10% ethyl acetate/dichloromethane)
to give O--(N-succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate as
a pale yellow powder (330 mg, 81%). .delta..sub.H (200 MHz,
DMSO-d.sub.6) 1.63-1.83 (6H, m), 2.74 (2H, t), 2.83 (4H, s), 4.47
(2H, app.t), 7.30-7.38 (2H, m), 7.81-7.84 (4H, m) and 8.34-8.38
(2H, m). Mass spectrum: (ES+) 407 (M+H), 429 (M+Na). Accurate mass:
(M+H)=C.sub.23H.sub.23N.sub.2O.sub.5, requires 407.1607. Found
407.1597 (-2.4 ppm).
2.
O--(N-Succinimidyl)-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate
##STR00014##
[0116] 2.1 O-Ethyl-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate and
O-ethyl-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate
[0117] O-Ethyl-6-(9-oxo-9H-acridin-10-yl)hexanoate (4.22 g, 12.5
mmol) was dissolved in ethanol (150 ml) with stirring. To the
resulting solution was added benzyltrimethylammoniun tribromide
(9.75 g, 25 mmol). The mixture was stirred under nitrogen for 4
days. The solvent was then evaporated under vacuum and the residue
partitioned between water (1000 ml) and ethyl acetate (300 ml). The
organic layer was collected, washed with more water and dilute
aqueous sodium thiosulfate solution, then dried (MgSO.sub.4),
filtered and evaporated under vacuum.
[0118] The crude product was purified by flash column
chromatography (silica. 0-5% ethyl acetate/dichloromethane).
O-Ethyl-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate eluted
first, followed by
O-ethyl-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate. Pure fractions
of each were pooled and evaporated separately.
[0119] O-Ethyl-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate was
recrystallized from ethanol. Yield: 2.77 g (53%). .lamda..sub.max
(EtOH)=412, 392, 300, 278, 256 nm. .delta..sub.H (300 MHz,
CD.sub.3OD) 1.22 (3H, t), 1.58 (2H, m), 1.74 (2H, m), 1.91 (2H, m),
2.37 (2H, t), 4.10 (2H, q), 4.49 (2H, app.t), 7.36 (1H, m), 7.72
(1H, d), 7.78 (1H, d), 7.82-7.92 (2H, m), 8.42 (1H, dd) and 8.52
(1H, dd). Mass spectrum: (ES+) 416 and 418 (M+H), 438 and 440
(M+Na).
[0120] O-Ethyl-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate was
recrystallized from chloroform/ethanol. Yield: 2.06 g (33%).
.delta..sub.H (200 MHz, DMSO-d.sub.6) 1.15 (3H, t), 1.50-1.80 (6H,
m), 2.31 (2H, t), 4.04 (2H, q), 4.43 (2H, app.t), 7.81 (2H, d),
7.95 (2H, dd) and 8.34 (2H, d).
2.2 6-(2-Bromo-9-oxo-9H-acridin-10-yl)hexanoic acid
[0121] O-Ethyl-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate (2.5 g,
6 mmol) was dissolved in acetic acid (30 ml). To this solution was
added 1.0M aqueous HCl (10 ml). The mixture was heated under reflux
for 3.5 hrs. Reverse phase chromatographic analysis (C.sub.18)
(methanol:water, 90:10) indicated two spots at R.sub.f=0.3 and
R.sub.f=0.55. The solution was then evaporated under vacuum, then
co-evaporated with acetonitrile until a yellow solid was obtained.
This was triturated with diethyl ether and dried under high vacuum
over phosphorus pentoxide to give
6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoic acid (2.27 g, 97%).
.delta..sub.H (200 MHz, DMSO-d.sub.6) 1.50-1.65 (4H, m), 1.70-1.81
(2H, m), 2.25 (2H, t), 4.46 (2H, app.t), 7.32-7.40 (1H, m),
7.78-7.98 (4H, m) and 8.31-8.41 (2H, m). .lamda..sub.max
(EtOH)=414, 397, 256 nm. Melting Point=213.degree. C.
2.3
O--(N-Succinimidyl)-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate
[0122] 6-(2-Bromo-9-oxo-9H-acridin-10-yl)hexanoic acid (388 mg, 1.0
mmol) and O--(N-succinimidyl)-N,N,N',N'-tetramethyluronium
tetrafluoroborate (TSTU; 301 mg, 1.0 mmol) were dissolved in
N,N-dimethylformamide (5 ml). To the resulting solution was added
N,N-diisopropylethylamine (183 .mu.l, 1.05 mmol). After 2 hrs the
solvent was evaporated under vacuum. The residue was purified by
flash chromatography (silica. 0-10% ethyl acetate/dichloromethane)
to give
O--(N-succinimidyl)-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate
(330 mg, 87%) .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.5-1.8 (6H,
m), 2.73 (2H, t), 2.80 (4H, s), 4.47 (2H, app.t), 7.32-7.42 (1H,
m), 7.78-7.83 (3H, m), 7.94 (1H, dd), 8.35 (1H, d) and 8.41 (1H,
d). Mass spectrum: (ES+) 485+487 (M+H), 507/509 (M+Na). Accurate
mass: (M+H)=C.sub.23H.sub.22BrN.sub.2O.sub.5, requires 485.0712.
Found 485.0689 (-4.8 ppm).
3.
O--(N-Succinimidyl)-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate
##STR00015##
[0123] 3.1 6-(2,7-Dibromo-9-oxo-9H-acridin-10-yl)hexanoic acid
[0124] O-Ethyl-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate (2.0
g, 4.04 mmol) was dissolved in acetic acid (30 ml). To this
solution was added 1.0M aqueous HCl (10 ml). The mixture was heated
under reflux for 4 hrs. Reverse phase chromatographic analysis
(C.sub.18) (methanol:water, 90:10) indicated two spots at
R.sub.f=0.2 and R.sub.f=0.4. The solution was allowed to cool to
ambient temperature, whereupon the product crystallized as fluffy
yellow needles. After final cooling in an ice bath, the solid was
collected by vacuum filtration, washed with cold aqueous acetic
acid, then diethyl ether and dried under vacuum over phosphorus
pentoxide to give 6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoic
acid (1.80 g, 97%). .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.50-1.80
(6H, m), 2.25 (2H, t), 4.40 (2H, app.t), 7.78 (2H, d), 7.92 (2H,
dd) and 8.3 (2H, d).
3.2
O--(N-Succinimidyl)-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate
[0125] 6-(2,7-Dibromo-9-oxo-9H-acridin-10-yl)hexanoic acid (467 mg,
1.0 mmol) and O--(N-succinimidyl)-N,N,N',N'-tetramethyluronium
tetrafluoroborate (TSTU; 301 mg, 1.0 mmol) were dissolved in
N,N-dimethylformamide (5 ml). To the resulting solution was added
N,N-diisopropylethylamine (183 .mu.l, 1.05 mmol). After leaving to
stand overnight, the is solvent was evaporated under vacuum. The
residue was purified by flash chromatography (silica. 10% ethyl
acetate/dichloromethane) to give
O--(N-succinimidyl)-6-(2,7-dibromo-9-oxo-9H-acridin-10-yl)hexanoate
(510 mg, 91%). .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.5-1.8 (6H,
m), 2.72 (2H, t), 2.83 (4H, s), 4.44 (2H, app.t), 7.82 (2H, d),
7.95 (2H, dd) and 8.36 (2H, d). Mass spectrum: (ES+) 563+565+567
(M+H), 585+587+589 (M+Na). Accurate mass:
(M+Na)=C.sub.23H.sub.20Br.sub.2N.sub.2O.sub.5Na, requires 584.9637.
Found 584.9608 (-4.9 ppm).
4.
O--(N-Succinimidyl)-6-(9-oxo-9H-acridin-4-carboxamido)hexanoate
##STR00016##
[0126] 4.1 4-Carboxyacridone
[0127] 2,2'-Iminodibenzoic acid (5.27 g, 20.5 mmol) was mixed with
phosphorus oxychloride (20 ml). The resulting pale yellow slurry
was heated to boiling. The slurry turned initially bright yellow,
then dissolved to give a deep red solution which was intensely
yellow at the meniscus. After 2 hrs at reflux, excess solvent was
evaporated under vacuum to give a dark oil. This was quenched with
ice, then diluted with 2.0M aqueous HCl (25 ml) and the resulting
dark solution re-heated to boiling. After 20 mins a solid
precipitated to and the mixture became very thick; another 20 mls
of water was then added to allow effective stirring. After 1.5 hrs,
the mixture was allowed to cool to ambient temperature. The yellow
solid was collected by vacuum filtration, washed well with water,
then acetone, and dried under vacuum to give 4-carboxyacridone
(4.61 g, 94%). .lamda..sub.max (EtOH)=408, 390, 256 nm.
.delta..sub.H (300 MHz, DMSO-d.sub.6) 7.24-7.33 (2H, m), 7.67-7.76
(2H, m), 8.17 (1H, d), 8.38 (1H, dd), 8.47 (1H, dd) and 11.9 (broad
s, partially exch). Mass spectrum: (ES+) 240 (M+H), 262 (M+Na).
Melting Point>300.degree. C.
4.2 6-(9-Oxo-9H-acridin-4-carboxamido)hexanoic acid
[0128] 4-Carboxyacridone (2.15 g, 9 mmol), was mixed with
N,N-dimethylformamide (15 ml) and N,N-diisopropylethylamine (1.6
ml, 9.2 mmol) and stirred under nitrogen to give a deep yellow
solution. To this was added
O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium
hexafluorophosphate (3.5 g, 9 mmol) and stirring continued for 2
hrs. During this time a thick yellow precipitate formed.
6-Aminohexanoic acid (1.45 g, 11 mmol) was then added and stirring
continued overnight. Reverse phase chromatographic analysis
(C.sub.18) (methanol:water, 80:20) indicated two spots at
R.sub.f=0.75 and R.sub.f=0.55. The reaction mixture was then poured
into 0.25M aqueous HCl (200 ml) and the precipitated product
collected by vacuum filtration, washing with more dilute HCl and
water. The still-damp solid was recrystallized from ethanol/water
and dried under vacuum over phosphorus pentoxide to give
6-(9-oxo-9H-acridin-4-carboxamido)hexanoic acid (1.97 g, 62%).
.lamda..sub.max (EtOH)=408, 390, 256 nm. .delta..sub.H (300 MHz,
DMSO-d.sub.6) 1.35-1.65 (6H, m), 2.24 (2H, t), 3.40 (2H, t),
7.26-7.39 (2H, m), 7.74-7.77 (2H, m), 8.21-8.28 (2H, m), 8.44 (2H,
app.d), 9.00 (1H, broad t, amide), 12.02 (broad s, D.sub.2O exch.)
and 12.49 (broad s, D.sub.2O exch.). Mass spectrum: MALDI-TOF,
m/z=353.15, M=353.15 for O.sub.20H.sub.21N.sub.2O.sub.4. Melting
Point=218.degree. C.
4.3
O--(N-Succinimidyl)-6-(9-oxo-9H-acridin-4-carboxamido)hexanoate
[0129] 6-(9-Oxo-9H-acridin-4-carbaxamido)hexanoic acid (352 mg, 1.0
mmol) and O--(N-succinimidyl)-N,N,N',N'-tetramethyluronium
tetrafluoroborate (TSTU; 301 mg, 1.0 mmol) were dissolved in
N,N-dimethylformamide (5 ml). To the resulting solution was added
N,N-diisopropylethylamine (183 .mu.l, 1.05 mmol). After leaving to
stand overnight the solvent was evaporated under vacuum. The
residue was purified by flash chromatography (silica. 10-100% ethyl
acetate/dichloromethane) to give
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-4-carbaxamido)hexanoate
(410 mg, 91%). .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.44-1.75 (6H,
m), 2.71 (2H, t), 2.79 (4H, s), 3.38 (2H, t), 7.27-7.39 (2H, m),
7.75 (2H, app.d), 8.21-8.28 (2H, m), 8.44 (1H, app.d), 9.00 (1H,
broad t, amide) and 12.47 (broad s, D.sub.2O exch.). Mass spectrum:
(ES+) 450 (M+H), 472 (M+Na). Accurate mass:
(M+H)=C.sub.24H.sub.24N.sub.3O.sub.6, requires 450.1665. Found
450.1671 (+1.3 ppm).
5. 2-Carboxymethyl-7-chloro-9-oxo-9,10-acridine
##STR00017##
[0130] 5.1 N-(4-Carboxymethylphenyl)-4-chloro-2-carboxyaniline
[0131] To a 100 ml round bottomed flask was added
2,5-dichlorobenzoic acid (1.9 g, 10 mmol), 4-aminophenylacetic acid
(1.5 g, 10 mmol), anhydrous sodium carbonate (3.2 g, 26 mmol),
activated copper metal powder (0.25 g, 4 mmol) and 1-butanol (50
ml). The flask was fitted with a magnetic stirrer bar, water
condenser, silica gel guard tube and heated under reflux for 48
hours. TLC (RPC.sub.18, Water, 20: methanol, 80) showed the
formation of a slower moving component at R.sub.f 0.55. The solvent
was removed under reduced pressure with final drying under high
vacuum. The residue was dissolved in 50 ml water and heated to
boiling, then charcoal was added and the mixture filtered through
celite, washing through with a further 25 ml of hot water. This
solution was cooled to 10.degree. C. in an ice bath and then
acidified to pH.apprxeq.2 with to concentrated aqueous HCl. The oil
that separated was extracted into chloroform, the solution dried
with anhydrous magnesium sulphate, filtered and the solvent removed
by rotary evaporation to leave a sticky solid. Recrystallization
from water/acetic acid gave the title compound (1.07 g, 35%).
.delta..sub.H (300 MHz, DMSO-d.sub.6) 3.54 (2H, s), 7.15-7.27 (5H,
m), 7.39 (1H, dd) 7.81 (1H, d), 9.54 (1H, broad s) and 12.0-13.5
(2H, broad). Mass spectrum: (ES-) 304 (M-H). .lamda..sub.max
(EtOH)=292, 364 nm.
5.2 2-Carboxymethyl-7-chloro-9-oxo-9,10-acridine
[0132] To a 25 ml round bottomed flask was added the diphenylamine
(500 mg, 1.64 mmol) and phosphorus oxychloride (5 ml). The flask
was fitted with a magnetic stirrer bar, water condenser, silica gel
guard tube and heated under reflux for 1 hour. The excess
phosphorus oxychloride was removed from the dark brown mixture
under vacuum, then a small amount of ice was added followed by 2.0M
aqueous HCl (10 ml). The mixture was heated to 100.degree. C. for 1
hour and allowed to cool, before being evaporated to dryness and
dried under vacuum over phosphorus pentoxide. The residue was
dissolved in 10% v/v water/methanol and eluted through a SepPak
RPC.sub.18 (10 g) column with monitoring by TLC. The
fluorescence-containing fractions were combined, evaporated to
dryness and dried under vacuum over phosphorus pentoxide.
[0133] This semi-purified material was then further purified by
preparative HPLC(RPC.sub.18. Water.fwdarw.methanol gradient). Pure
fractions were combined and evaporated to give
2-carboxymethyl-7-chloro-9-oxo-9,10-acridine as a pale yellow solid
(19 mg, 4%). .delta..sub.H (300 MHz, DMSO-d.sub.6) 3.72 (2H, s),
7.50 (1H, m), 7.58 (1H, m), 7.65 (1H, m), 7.75 (1H, m), 8.10 (1H,
m), 8.14 (1H, m) and 11.9+12.4 (2.times. broad s). Mass spectrum:
(ES-) 286+288 (M-H), 242+244 (M-H--CO.sub.2). .lamda..sub.max
(EtOH)=260, 390, 408 nm.
6. N-(Succinyl)-2-amino-10H-acridine-9-one
##STR00018##
[0135] 2-Amino-10H-acridine-9-one (100 mg, 0.48 mM), succinic
anhydride (50 mg, 0.5 Mm), diisopropylethylamine (90 .mu.l) and dry
DMF (1 ml) were stirred together overnight. TLC (C-18 reverse phase
plates, water:methanol 1:1) indicated that all the starting
material (green fluorescence under long wavelength UV light) had
been converted to a faster running spot, which showed blue
fluorescence under long wavelength UV light. The solvent was
removed by rotary evaporation, the residue dissolved in
dichloromethane and purified by flash column chromatography
(silica, 0-10% methanol/dichloromethane). Pure fractions of each
were pooled and evaporated to dryness to give
N-(succinyl)-2-amino-10H-acridine-9-one, 147 mg (98%).
.lamda..sub.max (H.sub.2O)=399 nm. .delta..sub.H (300 MHz,
d.sub.6-DMSO) 2.05 (4H, m), 6.82 (1H, t), 7.15 (2H, m), 7.28 (1H,
t), 7.53 (1H, d), 7.81 (1H, d), 8.09 (1H, s). Mass spectrum: (ES+)
311. M.Pt>300.degree. C.
7. 2-Nitroacridone-7-sulphonic acid
##STR00019##
[0136] 7.1 2-Carboxy-4-nitrodiphenylamine
[0137] 2-Chloro-5-nitrobenzoic acid (15 g, 75 mmol) was mixed with
1-butanol (100 ml) and stirred. To the resulting mixture was added
aniline (15 ml, 15.3 g, 165 mmol) and N,N-diisopropylethylamine
(28.8 ml, 21.3 g, 165 mmol). The resulting light yellow solution
was heated under reflux for 4 days, during which time the colour
changed to deep yellow. TLC (RPC.sub.18, Methanol, 80:water, 20.
R.sub.f=0.75, yellow: R.sub.f 2-chloro-5-nitrobenzoic
acid=0.85).
[0138] The solvent was evaporated under vacuum as much as possible.
The residual oil was triturated with water acidified with aqueous
HCl to maintain a pH of 2-4. A yellow solid eventually separated.
This was collected by vacuum filtration, washed well with excess
water and allowed to suck dry over 15 minutes. The crude product
was purified by mixing with acetic acid (150 ml), then heating to
boiling and allowing the resulting mixture to cool slowly to
ambient temperature with stirring. The bright yellow solid so
obtained was collected by vacuum filtration, washed with acetic
acid followed by excess diethyl ether and dried under vacuum over
phosphorus pentoxide to give 2-carboxy-4-nitro-diphenylamine (12.02
g, 62%). .delta..sub.H (200 MHz, DMSO-d.sub.6) 7.14 (1H, d),
7.24-7.52 (5H, m), 8.18 (1H, dd), 8.72 (1H, d) and 10.38 (1H, broad
s).
7.2 2-Nitroacridone
[0139] 2-Carboxy-4-nitrodiphenylamine (5.16 g, 20 mmol) was mixed
with phosphorus oxychloride (20 ml). The resulting yellow slurry
was heated under reflux for 3 hrs, during which time the solids
dissolved to give a dark solution (intensely yellow at the
meniscus). The excess phosphorus oxychloride was then evaporated
under vacuum; the resulting oil was carefully quenched with ice
before addition of 1.0M aqueous HCl (100 ml). The mixture was then
heated to boiling, whereupon acetic acid (up to 20 ml) was slowly
added down the condenser to aid dispersion of the immiscible oil.
On continued boiling for 1 hour, a yellow slurry resulted. After
subsequent cooling, this solid was collected by vacuum filtration,
washed with excess water, then acetone and finally diethyl ether,
before drying under vacuum over phosphorus pentoxide to give
2-nitroacridone (4.66 g, 97%). .delta..sub.H (200 MHz,
DMSO-d.sub.6) 7.39 (1H, app.t), 7.60 (1H, d), 7.68 (1H, d), 7.84
(1H, app.t), 8.25 (1H, d), 8.48 (1H, dd), 8.98 (1H, d) and 12 38
(1H, broad s).
7.3 2-Nitroacridone-7-sulphonic acid
[0140] 2-Nitroacridone (25 mg) was mixed with fuming sulphuric acid
(.about.20% free SO.sub.3, 2.5 ml) to give a reddish solution. This
was heated at 100.degree. C. for 90 mins, to give a yellowish
solution. After cooling, the mixture was quenched dropwise into ice
(.about.15 g); 6 ml of concentrated HCl were added and the mixture
left to stand to precipitate out the product. The resulting pale
yellow solid was collected by vacuum filtration, washed with a
little 4.0M aqueous HCl, then redissolved in water and filtered
into a clean flask. The water was evaporated under vacuum to leave
2-nitroacridone-7-sulphonic acid as a yellow-brown solid. TLC acid
(RPC.sub.18, Methanol, 80: water, 20. R.sub.f=0.8, yellow. Mass
spectrum: (ES+) 321 (M+H); accurate mass:
(M+H)=C.sub.13H.sub.3N.sub.2O.sub.6S requires 321.0181. Found
321.0187 (1.8 ppm).
8.
O--(N-Succinimidyl)-6-(2-acetamido)-9-oxo-9H-acridin-10-yl)hexanoate
##STR00020##
[0141] 8.1 O-Ethyl-6-(2-nitro-9-oxo-9H-acridin-10-yl)hexanoate
[0142] 2-Nitroacridone (2.4 g; 10 mmol) was stirred with anhydrous
methyl sulphoxide (25 ml) under a nitrogen atmosphere. After 5
minutes, sodium hydride (60% dispersed in oil, 480 mg; 12 mmol) was
added to the yellow solution. Stirring was continued for 90 mins.
during which time the solution turned magenta. Ethyl
6-bromohexanoate (2.67 ml; 12 mmol) was added and stirring
continued overnight. The reaction mixture was poured into water
(300 ml) and the yellow precipitate was collected by filtration,
washed with water and dried under vacuum. The solid was dissolved
in dichloromethane and anhydrous magnesium sulphate added to the
solution. After filtration, the solution was evaporated to dryness
to leave a yellow-brown solid. The crude product was purified by
flash chromatography (silica. 0-5% ethyl acetate/dichloromethane)
to give 1.19 g (50%) of
O-ethyl-6-(2-nitro-9-oxo-9H-acridin-10-yl)hexanoate.
[0143] .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.2 (3H, t), 1.7 (6H,
m), 2.3 (2H, t), 4.05 (2H, q), 4.55 (2H, m), 7.45 (1H, m), 7.92
(2H, d), 8.03 (1H, d), 8.35 (1H, d), 8.50 (1H, dd), 9.03 (1H,
d).
8.2 O-Ethyl-6-(2-amino-9-oxo-9H-acridin-10-yl)hexanoate
[0144] O-Ethyl-6-(2-nitro-9-oxo-9H-acridin-10-yl)hexanoate (1.91 g;
5.0 mmol) and ammonium formate (1.58 g; 25 mmol) were dissolved in
ethanol (100 ml) to give a yellow solution. The solution was
stirred under nitrogen and a catalytic amount of 5% palladium on
carbon was added. Stirring was continued for 5 hrs. The solution
was then filtered through celite and the solvent removed by rotary
evaporation. The residue was dissolved in dichloromethane and
extracted with water. The organic layer was dried with anhydrous
magnesium sulphate, filtered and the solvent removed by rotary
evaporation. The crude product was purified by flash chromatography
(silica. 4-6% methanol/dichloromethane) to give 1.66 g
[0145] (94%) of
O-ethyl-6-(2-amino-9-oxo-9H-acridin-10-yl)hexanoate. .delta..sub.H
(200 MHz, DMSO-d.sub.6) 1.15 (3H, t), 1.6 (6H, m), 2.35 (2H, t),
4.05 (2H, dd), 4.4 (2H, t), 5.3 (2H, s), 7.2 (2H, m), 7.6 (4H, m),
8.3 (1H, d).
8.3 6-(2-Amino-9-oxo-9H-acridin-10-yl)hexanoic acid
[0146] O-Ethyl-6-(2-amino-9-oxo-9H-acridin-10-yl)hexanoate (350 mg;
1.0 mmol) was dissolved in acetic acid (5 ml) and 1.0M hydrochloric
acid (2 ml) and refluxed for 4 hrs. The solvent was removed by
rotary evaporation, the residue dissolved in acetic acid and
evaporated to dryness and the process repeated twice using
acetonitrile as solvent. The residue was dried under vacuum to give
370 mg of 6-(2-amino-9-oxo-9H-acridin-10-yl)hexanoic acid.
8.4 6-(2-Acetamido-9-oxo-9H-acridin-10-yl)hexanoic acid
[0147] 6-(2-Amino-9-oxo-9H-acridin-10-yl)hexanoic acid (370 mg:
1.14 mmol) was dissolved in anhydrous pyridine (10 ml) and acetic
anhydride (100 .mu.l) followed by diisopropylethylamine (350
.mu.l). The mixture was stirred for 3 hours. The solution was
evaporated to dryness under vacuum and the gummy residue dissolved
in dichloromethane. The solution was washed with 1.0M hydrochloric
acid and then brine. The organic phase was dried with anhydrous
magnesium sulphate, filtered and the solvent removed by rotary
evaporation to leave a sticky solid. Trituration with ether gave a
solid which was dried under vacuum to give 360 mg (86%) of
6-(2-acetamido-9-oxo-9H-acridin-10-yl)hexanoic acid.
8.5
O--(N-Succinimidyl)-6-(2-acetamido-9-oxo-9H-acridin-10-yl)hexanoate
[0148] 6-(2-Acetamido-9-oxo-9H-acridin-10-yl)hexanoic acid (360 mg;
1.0 mmol) and O--(N-succinimidyl)-N,N,N',N'-tetramethyluronium
tetrafluoroborate (350 mg; 1.0 mmol) were dissolved in anhydrous
dimethylformamide (5 ml) and diisopropylethylamine (183 .mu.l)
added. The yellow solution was stirred under nitrogen for 1 hour.
The solvent was removed by rotary evaporation to leave a brown gum.
This was purified by flash chromatography (silica. 10%
methanol/ethyl acetate) to give 330 mg (50%) of
O--(N-succinimidyl)-6-(2-acetamido-9-oxo-9H-acridin-10-yl)hexano-
ate. .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.8 (6H, m), 2.1 (3H,
s), 2.9 (6H, m), 4.5 (2H, m), 7.3 (1H, m), 7.8 (3H, m), 8.05 (1H,
d), 8.35 (1H, d), 8.6 (1H, s), 10.2 (1H, s). Accurate mass.
(M+H)=C.sub.25H.sub.26N.sub.3O.sub.6, requires 464.1822. Found
464.1798 (5.1 ppm).
9.
O--(N-Succinimidyl)-6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanoate
##STR00021##
[0149] 9.1 6-(2-Sulpho-9-oxo-9H-acridin-10-yl)hexanoic acid
[0150] O-Ethyl-6-(9-oxo-9H-acridin-10-yl)hexanoate (2.0 g; 6.0
mmol) was dissolved in conc. sulphuric acid (10 ml) and the
solution heated to 120.degree. C. for 20 hrs. The mixture was
allowed to cool and added to .about.50 gm of crushed ice. The
precipitate was collected by centrifugation, washed with 3.0M
hydrochloric acid and dried under vacuum and over phosphorous
pentoxide to give 2.1 g (90%) of
6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanoic acid. .delta..sub.H
(200 MHz, DMSO-d.sub.6) 1.7 (6H, m), 2.26 (2H, t), 4.5 (2H, t),
7.37 (1H, m), 7.9 (5H, m), 8.37 (1H, d), 8.58 (1H, d). Mass
spectrum: (ES+) (M+H) 390.
9.2
O--(N-Succinimidyl)-6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanoate
[0151] 6-(2-Sulpho-9-oxo-9H-acridin-10-yl)hexanoic acid (100 mg;
0.25 mmol) was dissolved in anhydrous dimethylformamide (3 ml) and
evaporated to dryness on a rotary evaporator. The process was
repeated to remove traces of water.
O--(N-Succinimidyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate
(90 mg; 0.3 mmol) was added and the mixture dissolved in anhydrous
dimethylformamide (2 ml) and diisopropylethylamine (90 .mu.l). The
yellow solution was stirred under nitrogen for 60 mins when TLC
(RP.sub.18 50:50 water:methanol) showed all the starting material
had been converted to a slower moving component. The solvent was
removed by rotary evaporation with final drying under high vacuum.
No further attempts were made to purify this material.
10. 6-(2-Bromo-7-sulpho-9-oxo-9H-acridin-10-yl)hexanoic acid
##STR00022##
[0153] O-ethyl-6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoate (2.08
gm; 5.0 mmol) was dissolved in conc. sulphuric acid (10 ml) and
heated to 120.degree. C. for 20 hrs. The mixture was allowed to
cool and added to .about.50 gm of crushed ice. The precipitate was
collected by centrifugation, washed with 3.0M hydrochloric acid and
dried under vacuum in the presence of phosphorous pentoxide to give
2.2 g (94%) of 6-(2-bromo-7-sulpho-9-oxo-9H-acridin-10-yl)hexanoic
acid. .delta..sub.H (200 MHz, DMSO-d.sub.6) 1.7 (6H, m), 2.25 (2H,
t), 4.5 (2H, m), 7.9 (4H, m), 8.42 (1H, d), 8.57 (1H, d). Mass
spectrum (ES+) (M+H) 468, 470.
11. N-(Maleimido)ethyl-6-(9-oxo-9H-acridin-10-yl)hexanamide
##STR00023##
[0154] 11.1 N-(Aminoethyl)maleimide hydrochloride
[0155] N-Butoxycarbonyl-2-(aminoethyl)maleimide (200 mg; 0.83 mmol)
was stirred under nitrogen with 4M hydrochloric acid in dioxan (4
ml). A white precipitate started to form after a few minutes.
Stirring was continued for 40 minutes and then the solvent was
removed by rotary evaporation. The resultant white solid was dried
under vacuum to give 180 mg (100%) of N-(aminoethyl)maleimide
hydrochloride. .delta..sub.H (200 MHz, CD.sub.3OD) 1.38 (2H, s), to
3.14 (2H, t), 3.81 (2H, t), 6.90 (2H, s).
11.2 N-(Maleimido)ethyl-6-(9-oxo-9H-acridin-10-yl)hexanamide
[0156] O--(N-Succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate (102
mg; 0.25 mmol) was dissolved in anhydrous dimethyl formamide (800
.mu.l) and diisopropylethylamine (53 .mu.l) added.
N-(Aminoethyl)maleimide hydrochloride (53 mg; 0.30 mmol) was added
to the yellow solution which was left to stand overnight. The
solvent was removed by rotary evaporation and the residue purified
by flash chromatography (silica. 2% methanol/dichloromethane).
After removal of the solvent by rotary evaporation a yellow oil
remained which slowly crystallised. Trituration with diethyl ether
completed the crystallisation. This material was further purified
by preparative TLC (silica. 5% methanol/dichloromethane) extracting
the required material with 10% methanol/dichloromethane.
[0157] Solvent was removed under vacuum, the residue triturated
with ether to give 65 mg (60%) of
N-(maleimido)ethyl-6-(9-oxo-9H-acridin-10-yl)hexanamide.
.delta..sub.H (200 MHz, DMSO-d.sub.6) 1.7 (6H, m), 2.02 (2H, t),
3.2 (2H, dd), 3.45 (2H, t), 4.45 (2H, t), 7.01 (2H, s), 7.35 (2H,
m), 7.85 (5H, m), 8.36 (2H, d). Mass spectrum (ES+) (M+H) 432.
12.
N-(Maleimido)ethyl-6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanamide
##STR00024##
[0159]
O--(N-Succinimidyl)-6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanoate
(90 mg; 0.15 mmol) was dissolved in anhydrous dimethyl formamide
(1.0 ml) and diisopropylethylamine (52 .mu.l) added.
N-(aminoethyl)maleimide hydrochloride (52 mg; 0.30 mmol) was added
to the yellow solution which was is left to stand overnight. The
solvent was removed by rotary evaporation and the residue purified
by HPLC (Vydac RP.sub.18 semi-preparative column, gradient of water
to 25% acetonitrile (both containing 0.1% trifluoroacetic acid)
over 30 minutes, detection at 400 nm) to give
N-(maleimido)ethyl-6-(2-sulpho-9-oxo-9H-acridin-10-yl)hexanamide.
13. 6-(2-Fluoro-9-oxo-9H-acridin-10-yl)hexanoic acid
##STR00025##
[0160] 13.1 N-(4-Fluorophenyl)anthranilic acid
[0161] 4-Fluoroaniline (1.86 gm; 20 mmol), 2-chlorobenzoic acid
(1.56 gm; 10 mmol), ethylene glycol (5 ml) and anhydrous sodium
carbonate (1.1 gm; 10 mmol) were placed in a reaction vessel and
stirred until effervescence ceased. Cupric chloride (100 mg; 0.75
mmol) dissolved in 2 ml of water was added to the reaction mixture
which was then heated to 125.degree. C. for 6 hrs. The reaction was
allowed to cool and water (30 ml) and charcoal were added. The
mixture was filtered and then acidified to pH 2 with conc.
hydrochloric acid. The precipitate was collected by filtration,
washed with water and then re-dissolved in 1M sodium hydroxide
solution. Material was re-precipitated by the addition of acetic
acid, filtered off, washed with aqueous acetic acid, then water and
finally dried under vacuum over phosphorous pentoxide to give 862
mg (37%) of N-(4-fluorophenyl)anthranilic acid.
13.2 2-Fluoroacridone
[0162] N-(4-Fluorophenyl)anthranilic acid (0.70 gm; 3 mmol) and
phosphorous oxychloride (3 ml) were stirred together and heated to
115.degree. C. for 3.5 hours, is then allowed to cool. The reaction
mixture was placed on ice and small pieces of ice added, a vigorous
reaction occurred with the evolution of hydrogen chloride. When the
reaction had subsided, water (15 ml) was added and the mixture was
boiled for 2 hours. On cooling, a solid precipitated out. This was
filtered off and washed with water until the filtrate was
colourless. The precipitate was further washed with cold methanol
then diethyl ether and dried under vacuum to give 383 mg (59%) of
2-fluoroacridone.
13.3 O-Ethyl-6-(2-fluoro-9-oxo-9H-acridin-10-yl)hexanoate
[0163] 2-Fluoroacridone (213 mg; 1.0 mmol) was dissolved in
anhydrous DMF (3 ml) under a nitrogen atmosphere. Sodium hydride
dispersed in oil (45 mg; 1.1 mmol) was added and the mixture
stirred until effervescence ceased. Ethyl 6-bromoacetate (250
.mu.l) was added and the mixture stirred at 70.degree. C.
overnight. The solvent was removed by rotary evaporation and the
yellow residue purified by flash chromatography (silica. 4% ethyl
acetate/dichloromethane) to give 230 mg (65%) of
O-ethyl-6-(2-fluoro-9-oxo-9H-acridin-10-yl)hexanoate. .delta..sub.H
(200 MHz, DMSO-d.sub.6) 1.20 (3H, t), 1.65 (6H, m), 2.35 (2H, t),
4.05 (2H, dd), 4.45 (2H, t), 7.35 (1H, m), 7.9 (5H, m), 8.35 (1H,
d). Mass spectrum (ES+) (M+H) 356.1
13.4 6-(2-Fluoro-9-oxo-9H-acridin-10-yl)hexanoic acid
[0164] O-Ethyl-6-(2-fluoro-9-oxo-9H-acridin-10-yl)hexanoate (71 mg;
0.2 mmol) was dissolved in ethanol (2 ml) and 1.0M sodium hydroxide
solution (0.4 ml) added and the mixture heated to 90.degree. C. for
90 minutes. The mixture was cooled and water (6 ml) added to give a
yellow precipitate. The mixture was to cooled on ice and acidified
with conc. hydrochloric acid when more material precipitated out.
The precipitate was filtered off, washed with water then ethanol
and dried under vacuum over phosphorous pentoxide to give 47 mg
(72%) of 6-(2-fluoro-9-oxo-9H-acridin-10-yl)hexanoic acid.
.delta..sub.H (200 MHz, DMSO-d.sub.6) 1.68 (6H, m), 2.25 (2H, t),
4.48 (2H, t), 7.36 (1H, m), 7.85 (5H, m), 8.34 (1H, d).
[0165] .lamda..sub.max(ab) 251 nm (.epsilon.=45,500/M.sup.-1
cm.sup.-1); 401 nm (.epsilon.=7980/M.sup.-1 cm.sup.-1); 421 nm
(.epsilon.=7980/M.sup.-1 cm.sup.-1). (PBS buffer).
.lamda..sub.max(em) 434 nm (PBS buffer)
14. 6-(2-Methoxy-9-oxo-9H-acridin-10-yl)hexanoic acid
##STR00026##
[0166] 14.1 N-(4-Methoxyphenyl)anthranilic acid
[0167] 4-Methoxyaniline (1.86 gm; 20 mmol), 2-chlorobenzoic acid
(1.56 gm; 10 mmol), ethylene glycol (5 ml) and anhydrous sodium
carbonate (1.1 gm; 10 mmol) were placed in a reaction vessel and
stirred until effervescence ceased. Cupric chloride (100 mg; 0.75
mmol) dissolved in 2 ml of water was added to the reaction mixture
which was then heated to 125.degree. C. for 6 hours. The reaction
was allowed to cool then water (30 ml) and charcoal were added. The
mixture was filtered and acidified to pH 2 with conc. hydrochloric
acid. The precipitate was collected by filtration, washed with
water and then re-dissolved in 1M sodium hydroxide solution.
Material was re-precipitated by the addition of acetic acid,
filtered off, washed with aqueous acetic acid, then water and
finally dried under vacuum over phosphorous pentoxide to give 1200
mg (49%) of N-(4-methoxyphenyl)anthranilic acid. Mass spectrum
(ES+) (M+H) 242
14.2 2-Methoxyacridone
[0168] Polyphosphoric acid (50 gm) was heated to 160.degree. C.
under a nitrogen atmosphere. N-(4-methoxyphenyl)anthranilic acid
(4.89 gm; 20 mmol) was added and the mixture stirred at 160.degree.
C. for 15 minutes. The reaction was is cooled rapidly in an ice
bath and water added to give a greenish yellow precipitate. This
was filtered off, washed with water, then dilute sodium bicarbonate
solution and again with water. The solid was finally dried at
50.degree. C. under vacuum to give 3.67 gm (81%) of
2-methoxyacridone. .delta..sub.H (200 MHz, DMSO-d.sub.6) 3.86 (3H,
s), 7.23 (1H, t), 7.55 (5H, m), 8.22 (1H, d), 11.7 (1H, s).
14.3 O-Ethyl-6-(2-methoxy-9-oxo-9H-acridin-10-yl)hexanoate
[0169] 2-Methoxyacridone (2.25 g; 10 mmol) was stirred with
anhydrous dimethyl formamide (15 ml) under a nitrogen atmosphere.
After 5 minutes, sodium hydride (60% dispersed in oil, 250 mg; 12
mmol) was added and the mixture stirred until effervescence ceased.
A second lot of sodium hydride (230 mg) was added and stirring
continued until effervescence ceased. Ethyl 6-bromohexanoate (2.67
ml; 15 mmol) was added to the yellow solution and stirring was
continued overnight. The reaction mixture was poured into water
(300 ml) and the mixture extracted with dichloromethane. The
organic phase was washed with 1.0M hydrochloric acid (2.times.150
ml) then dried over anhydrous magnesium sulphate. After filtration,
the solvent was removed by rotary evaporation to give a dark
coloured oil. This was purified by flash chromatography (silica. 5%
ethanol/dichloromethane) to give a yellow oil which crystallised on
trituration with diethyl ether/hexane to give 0.83 g (23%) of
O-ethyl-6-(2-methoxy-9-oxo-9H-acridin-10-yl)hexanoate. Mass
spectrum (ES+) (M+H) 367 (M+Na) 389.
14.4 6-(2-Methoxy-9-oxo-9H-acridin-10-yl)hexanoic acid
[0170] O-Ethyl-6-(2-methoxy-9-oxo-9H-acridin-10-yl)hexanoate (367
mg; 1.0 mmol) was dissolved in ethanol (10 ml) and 1.0M sodium
hydroxide solution (2.0 ml) added and the mixture heated to
90.degree. C. for 1 hour. The mixture was cooled and water (20 ml)
added. The mixture was cooled on ice and acidified with conc.
hydrochloric acid when a yellow oil separated. The oil slowly
crystallised to a bright yellow solid. This was filtered off,
washed with water and dried under vacuum to give 327 mg (96%) of
6-(2-methoxy-9-oxo-9H-acridin-10-yl)hexanoic acid. .delta..sub.H
(200 MHz, DMSO-d.sub.6) 1.7 (6H, m), 2.25 (2H, t), 3.9 (3H, s), 4.5
(2H, t), 7.31 (1H, m), 7.48 (1H, dd), 7.82 (4H, m), 8.35 (1H, d).
.lamda..sub.max(ab) 255 nm (.epsilon.=38,100/M.sup.-1 cm.sup.-1);
408 nm (.epsilon.=7150/M.sup.-1 cm.sup.-1); 428 nm
(.epsilon.=7150/M.sup.-1 cm.sup.-1). (PBS buffer).
.lamda..sub.max(em) 467 nm. (PBS buffer).
15. Fluorescence Lifetime Studies
[0171] Fluorescence lifetimes were determined by time-correlated
single photon counting using an Edinburgh Instruments FL900CDT Time
Resolved T-Geometry Fluorimeter. Samples were excited at 400 nm
using a hydrogen arc lamp. Detection was at 450 nm. Deconvolution
using a non-linear least squares algorithm gave the results shown
in Table 2. FIG. 2 is a plot showing the fluorescence lifetimes of
certain acridone dyes according to the invention.
TABLE-US-00002 TABLE 2 Fluorescence Lifetimes Lifetime Compound
Solvent (nsecs) N-(Succinyl)-2-amino-10H-acridine-9-one water 17.2
2-Carboxymethyl-7-chloro-9-oxo-9,10-acridine MeOH 16.8
6-(2,7-Disulphonato-9-oxo-9H-acridin-10-yl)hexanoic water 14.6 acid
6-(9-Oxo-9H-acridin-10-yl)hexanoic acid water/ 14.2 MeOH 50/50)
6-(2-Bromo-9-oxo-9H-acridin-10-yl)hexanoic acid MeOH 8.3
6-(2,7-Dibromo-9-oxo-9H-acridin-10-yl)hexanoic acid MeOH 4.5
6-(9-Oxo-9H-acridin-4-carboxamido)hexanoic acid water/ 4.2 MeOH
(50/50) 2-Nitroacridone-7-sulphonic acid water non- fluorescent
6-(2-Acetamido-9-oxo-9H-acridin-10-yl)hexanoic acid water 17
6-(2-Sulpho-9-oxo-9H-acridin-10-yl)hexanoic acid water 13.3
6-(2-Bromo-7-sulpho-9-oxo-9H-acridin-10-yl)hexanoic water 5.6 acid
6-(2-Fluoro-9-oxo-9H-acridin-10-yl)hexanoic acid water 14
6-(2-Methoxy-9-oxo-9H-acridin-10-yl)hexanoic acid water 17
16. Protein Labelling
16.1 Preparation of 6-(9-oxo-9H-acridin-10-yl)hexanoic acid--bovine
serum albumin (BSA) conjugate (Conjugate 1)
[0172] To 10 ml of bovine serum albumin (1 mg/ml in 0.1 M carbonate
buffer, pH9.3), 100 .mu.l
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate (1 mg/100
.mu.l in DMSO) was added dropwise whilst stirring. Gentle stirring
continued for 1 hr at ambient temperature in a foil wrapped vial.
Unconjugated dye was removed by overnight dialysis (12-14K MWCO) at
4.degree. C. with at least 2 is changes of PBS. Conjugate 1 was
recovered and stored at 4.degree. C.
16.2 Preparation of 6-(9-oxo-9H-acridin-4-carboxamido)hexanoic
acid--rabbit serum albumin conjugate (Conjugate 2)
[0173] To 10 ml of rabbit serum albumin (1 mg/ml in 0.1 M carbonate
buffer, pH9.3), 100 .mu.l
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-4-carboxamido)hexanoate (1
mg/100 .mu.l in DMSO) was added dropwise whilst stirring. Gentle
stirring continued for 1 hr at ambient temperature in a foil
wrapped vial. Unconjugated dye was removed by overnight dialysis
(12-14K MWCO) at 4.degree. C. with at least 2 changes of PBS.
Conjugate 2 was recovered and stored at 4.degree. C.
16.3 Determination of the Fluorescence Lifetimes of Conjugates 1
and 2
[0174] The fluorescence lifetimes of a mixture of conjugates 1 and
2 were determined in PBS. The results are shown in FIG. 3.
Deconvolution and curve fitting using a non-linear least-squares
algorithm gave the results shown in Table 3.
TABLE-US-00003 TABLE 3 Lifetime Relative Sample (ns) % Conjugate 1
14.0 40.2 5.5 45.6 1.2 14.3 Conjugate 2 4.6 49.4 1.2 35.0 19.3
15.6
16.4 Immunoprecipitation Assay
[0175] To 500 .mu.l of PBS in a 1.5 ml centrifuge tube was added
200 .mu.l conjugate 1 and 200 .mu.l conjugate 2. After mixing, 450
.mu.l was removed into a silica cuvette for determination of the
fluorescence lifetime using excitation at 405 nm, emission at 450
nm by a time-correlated single photon counting technique (Edinburgh
Analytical Instruments FL900CDT spectrometer). To the 450 .mu.l in
the centrifuge tube, 100 .mu.l of anti-BSA antibody was added.
After incubation for 30 min at 37.degree. C., then 1 hr incubation
at 4.degree. C., the tube was centrifuged for 5 min in a bench-top
centrifuge. The pellet was washed twice with ice-cold PBS, then
re-suspended in 0.1 M NaOH. The fluorescence lifetime of this
solution was determined as above. The results are shown in FIG. 4.
Deconvolution and curve fitting using a non-linear least-squares
analysis algorithm gave the results shown in Table 4.
TABLE-US-00004 TABLE 4 Lifetime Fits for Immunoprecipitation Assay
Lifetime Relative Sample (ns) % Initial mixture 14.7 33.3 5.0 47.5
0.9 19.2 Re-suspended pellet 13.1 70.3 4.7 22.8 0.7 6.9
[0176] The results show that the relative percentage of conjugate 1
(lifetime range 13-15 ns) has increased significantly in the
pellet, as a result of the immunoprecipitation by the anti-BSA
antibody. The proportion of conjugate 2 (lifetime range 4.5-5 ns)
in the re-suspended pellet is correspondingly decreased, relative
to the proportion in the initial mixture. Although the
immunoprecipitation process was not completely efficient, analysis
using fluorescence lifetime has enabled the resolution of two
species (conjugate 1 and conjugate 2) in mixtures which are
indistinguishable by their emission wavelength.
17. Fluorescence Lifetime Detection in Capillary Electrophoresis of
Acridone Dye-Labelled DNA Fragments
[0177] M13 DNA primers were labelled using standard techniques with
each of four acridone dyes according to the present invention, i.e:
[0178] i) 6-(2-(acetylamino)-9-oxo-9H-acridin-10-yl)hexanoic acid,
[0179] ii) 6-(9-oxo-9H-acridin-10-yl)hexanoic acid, [0180] iii)
6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoic acid, and [0181] iv)
6-(9-oxo-9H-acridin-4-carboxamido)hexanoic acid. The succinimidyl
ester of each dye was conjugated to an amine-modified M13 forward
sequencing primer in 0.1 M carbonate pH 9.3/DMF (final composition
2:1). Purification by HPLC on a C18 column used a triethylammonium
bicarbonate/MeCN solvent system.
[0182] Real-time fluorescence lifetime detection was achieved by
interfacing a commercial multiharmonic Fourier transform (MHF)
fluorescence lifetime instrument (Model 4850 MHF, Spectronics
Instruments, Rochester, N.Y.) to a Beckman P/ACE 5000 CE system
(Li, L. et al, J. Chromatogr. B, (1997), 695, 85-92). The
excitation source was a continuous wave violet diode laser that
supplied 25-30 mW at 405 nm. The laser beam was focused onto the
detection window of the capillary using either a 45 mm focusing
lens or a 6.3.times. microscope objective with a focal length of 22
mm. The emission signal was collected by a 40.times. microscope
objective. Emission was selected through a 435 nm long pass filter.
A cross-correlation frequency of 9.4 Hz was used in the lifetime
measurements, resulting in 9.4 phase and modulation measurements
per second. Ten successive measurements were then averaged prior to
data analysis to yield approximately one lifetime measurement per
second. Scattered light from the capillary provided the lifetime
reference.
[0183] Solutions of 0.5 mM dye-labelled primer in 100 mM Tris
buffer, pH 8.6, were injected into the bare 75 .mu.M internal
diameter capillary for 10 s each at 10 kV injection voltage. The
separation voltage was 18 kV (250 V/cm). The replaceable gel matrix
contained 2% POP-6 gel in 3.5.times.POP-6 buffer. The lifetime
electropherogram as shown in FIG. 5 was obtained for successive
injections of M13 DNA primers labelled with each of the four dyes.
The solid line is the intensity and the dots correspond to
lifetimes recovered from a 1-component fit using non-linear least
squares analysis software (Globals, Inc). The results show that the
fluorescence lifetime (dots) coincides with the fluorescence
intensity peaks (line) as the dye labelled M13 primers migrate past
the detector.
18. Multiplexing Fluorescence Lifetime Determination
[0184] The following fluorescent acridone dye derivatives were
prepared as 1 mg/ml stock solutions in methanol: [0185] a)
6-(9-oxo-9H-acridin-10-yl)hexanoic acid; [0186] b)
6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoic acid; and [0187] c)
6-(9-oxo-9H-acridin-4-carboxamido)hexanoic acid.
[0188] The methanolic stock solutions were diluted (1/100) into 12%
polyacrylamide mix which was allowed to polymerize directly in
disposable cuvettes. Mixtures of the dyes were similarly prepared.
The fluorescence lifetimes of samples containing single, or
mixtures of dyes in polyacrylamide gel, were recorded by a
time-correlated single photon counting technique (Edinburgh
Analytical Instruments FL900CDT spectrometer). Samples were excited
at 400 nm using a hydrogen arc lamp, detection was at 450 nm.
Deconvolution using a non-linear least squares algorithm gave the
results shown in Table 5.
TABLE-US-00005 TABLE 5 Principal Lifetime Relative Sample (ns) % a)
6-(9-oxo-9H-acridin-10-yl)hexanoic acid 14.0 96.8 b)
6-(2-bromo-9-oxo-9H-acridin-10-yl)hexanoic acid 9.0 77.1 c)
6-(9-oxo-9H-acridin-4-carboxamido)hexanoic 3.6 74.4 acid a) + c)
14.0 74.5 3.9 25.5 b) + c) 9.5 49.7 4.0 50.3 a) + b) + c) 14.3 55.5
7.9 26.7 3.5 17.9
[0189] The results show that multiple lifetime components are
reported when the dyes are analysed in PAGE. However, the principal
lifetime component of each of the single dyes can still be
distinguished in mixtures of the dyes in PAGE. Thus, with prior
knowledge of the lifetime components present, the potential to
multiplex fluorescence lifetimes has been demonstrated.
19. Co-localisation of Bovine Serum Albumin (BSA) Labelled with
Different Acridone Dyes Using SDS PAGE
19.1 Preparation of 6-(9-oxo-9H-acridin-4-carboxamido)hexanoic
acid--bovine serum albumin (BSA) conjugate (Conjugate 3)
[0190] To 1 ml of BSA (10.0 mg/ml in 0.1M NaHCO.sub.3 solution) was
added a solution of
O--(N-succinimidyl)-6-(9-oxo-9H-acridin-4-carboxamido)hexanoate
(lifetime 4 ns) (25 .mu.l; 0.3125 mg/ml in DMSO). The resulting
mixture was incubated at room temperature for 30 minutes with
occasional mixing. A PD10 column (Amersham Biosciences) was
equilibrated with 10 ml of phosphate buffered saline (PBS; pH 7.4).
The dye-labelled BSA was added to the column, the column washed
with PBS (2 ml) and then eluted with 3 ml of PBS. The eluate was
collected to yield Conjugate 3.
19.2 Preparation of 6-(9-oxo-9H-acridin-10-yl)hexanoic acid--bovine
serum albumin (BSA) conjugate (Conjugate 4)
[0191] To 1 ml of BSA (10.0 mg/ml in 0.1 M NaHCO.sub.3) was added a
solution of O--(N-succinimidyl)-6-(9-oxo-9H-acridin-10-yl)hexanoate
(lifetime 14 ns) (2 mg in 100 .mu.l of DMSO). The resulting mixture
was incubated at room temperature for 30 minutes with occasional
mixing. A PD10 column (Amersham Biosciences) was equilibrated with
10 ml of phosphate buffered saline (PBS; pH 7.4). The dye-labelled
BSA was added to the column, the column washed with PBS (2 ml) and
then eluted with 3 ml of PBS. The eluate was collected to yield
Conjugate 4.
19.3 Sample Preparation and Electrophoresis
[0192] Conjugates 3 and 4 prepared as above, were mixed together in
a ratio of 2:1 in 0.05M Tris (20 .mu.l; buffered to pH 7.5 with
acetic acid containing 1% w/v sodium dodecyl sulphate, Bromophenol
Blue (10 mg/100 ml) and dithiothrietol (154 mg/100 ml) (Amersham
Biosciences). Protein samples were reduced by heating to 95.degree.
C. for 3 minutes. Electrophoresis was performed using a MultiPhor
II flat bed electrophoresis system with ExcelGel SDS buffer strips
(anode strip: 0.45 mol/Tris/acetate pH 6.6, 4 g/L SDS and 0.05 g/L
Orange G; cathode strip: 0.08 mol/L Tris, 0.80 mol/L Tricine and
6.0 g/L SDS pH 7.1). Duplicate samples were applied to the surface
of a pre-formed Excel 8-18 SDS PAGE gradient gel (Amersham
Biosciences) using a paper sample application strip placed at
locations corresponding with 96-well microplate centres required
for scanning the gel. Molecular weight markers were run in separate
lanes, so that part of the gel could be stained using Coomassie
Blue to check the integrity of the samples, monitor molecular
weight and to orientate the gel for lifetime scanning.
Electrophoresis was initiated at constant current to a maximum
voltage of 500V for 85 minutes with the flat bed temperature
maintained at 15.degree. C. Prior to scanning, the gel was fixed in
aqueous solution of 25% methanol, 5% acetic acid v/v for at least
30 minutes. Following lifetime scanning, the gel was stained for
10-20 minutes in 0.1% Coomassie Blue G-250 in aqueous solution of
25% methanol, 5% acetic acid v/v and de-stained in aqueous solution
of 25% methanol, 5% acetic acid v/v.
19.4 Scanning
[0193] Fixed gels were scanned with single wavelength laser
excitation at 405 nm and the gel sampled at approximately 2 mm
intervals along the axis of the electrophoretic separation. Data
was analysed using a Bayesian algorithm to assign fluorescence
intensity to fluorescence lifetimes of 2 ns (gel background); 4 ns
(4 ns acridone dye); 6 ns (intrinsic BSA lifetime); and 14 ns (14
ns acridone dye).
[0194] FIG. 6 shows the 4 ns dye-labelled BSA and the 14 ns
dye-labelled BSA (mixed in a ratio of 2:1) and co-electrophoresed
in the same gel lane. Two peaks are resolved at 4 ns and 14 ns,
both corresponding to the position of BSA relative to molecular
weight markers. The two labelled BSA species are co-located but
distinguishable by lifetime discriminated intensity. Both BSA
species are resolved by the gel to the same location in the gel as
indicated by reference to molecular weight markers and post
electrophoresis staining (66 kD).
[0195] The above mentioned examples of conceivable embodiments are
intended to illustrate the present invention and are not intended
to limit the scope of protection claimed by the following
claims.
* * * * *